Profil

Plenevaux Alain

See author's contact details
ORCID
0000-0003-3011-4984
Main Referenced Co-authors
Luxen, André  (190)
Lemaire, Christian  (184)
Bahri, Mohamed Ali  (119)
Aerts, Joël  (64)
Salmon, Eric  (54)
Main Referenced Keywords
PET (27); SV2A (24); microPET (20); fluorine-18 (12); Animals (11);
Main Referenced Unit & Research Centers
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège [BE] (234)
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (7)
Brookhaven National Laboratory NY USA (3)
CERMEP Lyon (3)
Centre Interfacultaire de Recherche du Médicament - CIRM (3)
Main Referenced Disciplines
Radiology, nuclear medicine & imaging (102)
Chemistry (98)
Life sciences: Multidisciplinary, general & others (36)
Biochemistry, biophysics & molecular biology (15)
Neurosciences & behavior (14)

Publications (total 295)

The most downloaded
781 downloads
Boveroux, P., Vanhaudenhuyse, A., Bruno, M.-A., Noirhomme, Q., Lauwick, S., Luxen, A., Degueldre, C., Plenevaux, A., Schnakers, C., Phillips, C., Brichant, J.-F., Bonhomme, V., Maquet, P., Greicius, M. D., Laureys, S., & Boly, M. (2010). Breakdown of within- and between-network resting state functional magnetic resonance imaging connectivity during propofol-induced loss of consciousness. Anesthesiology, 113 (5), 1038-53. doi:10.1097/ALN.0b013e3181f697f5 https://hdl.handle.net/2268/83850

The most cited

491 citations (Scopus®)

Boveroux, P., Vanhaudenhuyse, A., Bruno, M.-A., Noirhomme, Q., Lauwick, S., Luxen, A., Degueldre, C., Plenevaux, A., Schnakers, C., Phillips, C., Brichant, J.-F., Bonhomme, V., Maquet, P., Greicius, M. D., Laureys, S., & Boly, M. (2010). Breakdown of within- and between-network resting state functional magnetic resonance imaging connectivity during propofol-induced loss of consciousness. Anesthesiology, 113 (5), 1038-53. doi:10.1097/ALN.0b013e3181f697f5 https://hdl.handle.net/2268/78335

Raman, R., Bahri, M. A., Degueldre, C., Caetano da Silva, C., Sanchez, C., Ostertag, A., Collet, C., Cohen-Solal, M., Plenevaux, A., Henrotin, Y., & Muller, M. (14 January 2024). A Zebrafish Mutant in the Extracellular Matrix Protein Gene efemp1 as a Model for Spinal Osteoarthritis. Animals, 14 (1), 74. doi:10.3390/ani14010074
Peer Reviewed verified by ORBi

Raman, R., Zappia, J., Nivelle, R., Bahri, M. A., Lavergne, A., Caetano da Silva Caroline, Degueldre Christian, Ostertag Agnes, Renn, J., Collet Corrine, Plenevaux, A., Solal Cohen Martine, Henrotin, Y., & Muller, M. (07 September 2022). Zebrafish Osteoblast Transcriptome reveals genes that encode bone extra cellular matrix proteins which on mutating affect bone development [Poster presentation]. Deutsche Gesellschaft for Martrixbiologie e.V. 2022 (DGMB 2022), Frankfurt am Main, Germany.
Peer reviewed

Raman, R., Salomao D’Cruz Alison, Dikoum Cyrille, Zappia, J., Anthony Mishal, Caetano da Silva Caroline, Nivelle, R., Lavergne, A., Degueldre Christian, Ostertag Agnes, Bahri, M. A., Renn, J., Collet Corrine, Plenevaux, A., Solal Cohen Martine, Henrotin, Y., & Muller, M. (2022). Osteoblast Transcriptome in 4 days old zebrafish larvae and the role of Fbln1 and Col10a1a bone extracellular matrix proteins during skeletal development [Paper presentation]. German Society for Matrix biology (Deutsche Gesellschaft fuer Matrixbiologie e.V.) DGMB 2022, Frankfurt am Main, Germany.

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., Beckers, A., & Hanson, J. (April 2022). Deciphering the role of the GPR101 orphan receptor in growth hormone hypersecretion [Poster presentation]. Keystone Symposia Conference, GPCRs: An Odyssey from Structure, Signaling and Regulation to Therapeutics, Snowbird, United States.

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., Beckers, A., & Hanson, J. (February 2022). Deciphering the role of the GPR101 orphan receptor in growth hormone hypersecretion [Paper presentation]. CIRM day, Liege, Belgium.

Becker, G., Lespine, L.-F., Bahri, M. A., Serrano Navacerrada, M. E., Lemaire, C., Luxen, A., Tirelli, E., & Plenevaux, A. (2022). Exercise against cocaine sensitization in mice: a [18F]fallypride micro-PET study. Brain Communications, 4 (1), 294. doi:10.1093/braincomms/fcab294
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Blacher, S., Bahri, M. A., Balteau, E., COUCKE, P., Noël, A., Plenevaux, A., & Martinive, P. (2021). Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study. Frontiers in Oncology. doi:10.3389/fonc.2021.784437
Peer Reviewed verified by ORBi

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., BECKERS, A., & Hanson, J. (October 2021). Deciphering the role of the GPR101 orphan receptor in growth hormone hypersecretion [Poster presentation]. 5th ERNEST meeting, Bari, Italy.

Salmon, E., Bahri, M. A., Plenevaux, A., Becker, G., Seret, A., Delhaye, E., Degueldre, C., Balteau, E., Lemaire, C., Luxen, A., & Bastin, C. (09 August 2021). In vivo exploration of synaptic projections in frontotemporal dementia. Scientific Reports, 11, 16092. doi:10.1038/s41598-021-95499-1
Peer Reviewed verified by ORBi

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., BECKERS, A., & Hanson, J. (July 2021). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11 [Poster presentation]. 1st Transatlantic ECI GPCR symposium.

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., BECKERS, A., & Hanson, J. (May 2021). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11 [Paper presentation]. FASEB, The Growth Hormone (GH)/ Prolactin (PRL) Family in Biology & Disease Conference.

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., BECKERS, A., & Hanson, J. (April 2021). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11 [Paper presentation]. Belgian Society of Physiology and Pharmacology.

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., Beckers, A., & Hanson, J. (April 2021). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11 [Paper presentation]. 4th ERNEST meeting.

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., BECKERS, A., & Hanson, J. (April 2021). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11 [Poster presentation]. American Society for Pharmacology and Experimental Therapeutics (ASPET), GPCR colloquium.

Goutal, S., Guillermier, M., Becker, G., Gaudin, M., Bramoulle,, Y., Luxen, A., Lemaire, C., Plenevaux, A., SALMON, E., Hantraye, P., Barret, O., & Van Camp, N. (2021). The pharmacokinetics of [(18)F]UCB-H revisited in the healthy non-human primate brain. EJNMMI Res, 11 (1), 36. doi:10.1186/s13550-021-00777-8
Peer reviewed

Jacques, S., Arjomand, A., Perée, H., COLLINS, P., Mayer, A., Lavergne, A., Wéry, M., Mni, M., Hego, A., Thuillier, V., Becker, G., Bahri, M. A., Plenevaux, A., Di Valentin, E., Oury, C., MOUTSCHEN, M., Delvenne, P., Paquot, N., & Rahmouni, S. (2021). Dual‑specificity phosphatase 3 deletion promotes obesity, non‑alcoholic steatohepatitis and hepatocellular carcinoma. Scientific Reports, 11, 5817. doi:10.1038/s41598-021-85089-6
Peer Reviewed verified by ORBi

Becker, G., Michel, A., Bahri, M. A., Mairet-Coello, G., Lemaire, C., Deprez, T., Freyssin, A., Jacquin, L., Hustadt, F., De Wolf, C., Caruso, M., Frequin, J.-M., Gillent, E., Bezard, E., Garraux, G., Luxen, A., Citron, M., Downey, P., & Plenevaux, A. (2021). Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[ 18 F]fluoro-L-m-tyrosine imaging and motor performances analysis. Neurobiology of Aging, 107, 142-152. doi:10.1016/j.neurobiolaging.2021.07.012
Peer Reviewed verified by ORBi

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., Beckers, A., & Hanson, J. (November 2020). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11 [Paper presentation]. GDR3545.

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., Beckers, A., & Hanson, J. (21 September 2020). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11. Nature Communications, 11 (1), 4752. doi:10.1038/s41467-020-18500-x
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpre, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (2020). Exploring with [(18)F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. Molecular Imaging and Biology. doi:10.1007/s11307-020-01488-7
Peer Reviewed verified by ORBi

Lecomte, F.* , Aerts, J.* , Plenevaux, A., Defraiteur, C., Chappuis-Hugon, F., Rozet, E., CHIAP, P., Luxen, A., Pichon, V., Hubert, P.* , & Hubert, C.*. (20 February 2020). Performance evaluation of a MIP for the MISPE-LC determination of p-[18F]MPPF and a potential metabolite in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 180. doi:10.1016/j.jpba.2019.113015
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., BECKERS, A., & Hanson, J. (2020). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11 [Paper presentation]. 9TH GDR3545 GPCR INTERNATIONAL MEETING.

Bastin, C.* , Bahri, M. A.* , Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (2020). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography. European Journal of Nuclear Medicine and Molecular Imaging, 47 (2), 390-402. doi:10.1007/s00259-019-04461-x
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Salmon, E., Bahri, M. A., Plenevaux, A., Becker, G., Seret, A., Giacomelli, F., Delhaye, E., Degueldre, C., Balteau, E., Luxen, A., & Bastin, C. (2020). PET-[18F]UCB-H for assessing synaptic density in FTD. Alzheimer's and Dementia: the Journal of the Alzheimer's Association, 16 (S4), 037156.
Peer Reviewed verified by ORBi

Nagachinta, S., Becker, G., Dammicco, S., Serrano Navacerrada, M. E., LEROI, N., Bahri, M. A., Plenevaux, A., Lemaire, C., Lopez, R., Luxen, A., & de la Fuente, M. (2020). Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces B: Biointerfaces, 188, 110793. doi:10.1016/j.colsurfb.2020.110793
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E.* , Bartholomé, O.* , Van den Ackerveken, P., Ferrara, A., Rogister, B., Plenevaux, A., & Tirelli, E. (2019). Anxiety-like features and spatial memory problems as a consequence of hippocampal SV2A expression. PLoS ONE, 1-20. doi:10.1371/journal.pone.0217882
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Golkowski, D., Larroque, S. K., VANHAUDENHUYSE, A., Plenevaux, A., Boly, M., Di Perri, C., Ranft, A., Schneider, G., Laureys, S., Jordan, D., BONHOMME, V., & Ilg, R. (June 2019). Changes in Whole Brain Dynamics and Connectivity Patterns during Sevoflurane- and Propofol-induced Unconsciousness Identified by Functional Magnetic Resonance Imaging. Anesthesiology, 130 (6), 898-911. doi:10.1097/ALN.0000000000002704
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Seret, A., Mestdagh, N., Mercier, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 May 2019). Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET. Molecules, 24 (9), 1705. doi:10.3390/molecules24091705
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2019). Tumor modifications recorded with IVIM and DCE-MRI after Neoadjuvant radiotherapy. Radiotherapy and Oncology, 133 (Supplement 1), 284 - S285. doi:10.1016/S0167-8140(19)30960-0
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpré, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (19 March 2019). Longitudinal in vivo evaluation of brain synaptic density with [18F]UCB-H through the different phases in the kainic acid rat model of temporal lobe epilepsy [Paper presentation]. 14th European Molecular Imaging Meeting, Glasgow, United Kingdom.

Manos-Turvey, A., Becker, G., Francotte, P., Serrano Navacerrada, M. E., Luxen, A., Pirotte, B., Plenevaux, A., & Lemaire, C. (11 February 2019). Fully Automated Synthesis and Evaluation of [ 18 F]BPAM121: Potential of an AMPA Receptor Positive Allosteric Modulator as PET Radiotracer. ChemMedChem, 14 (7), 788-795. doi:10.1002/cmdc.201800816
Peer Reviewed verified by ORBi

Lespine, L.-F., Plenevaux, A., & Tirelli, E. (28 January 2019). Wheel-running exercise before and during gestation against acute and sensitized cocaine psychomotor-activation in offspring. Behavioural Brain Research, 363, 53-60. doi:10.1016/j.bbr.2019.01.049
Peer Reviewed verified by ORBi

VOTTERO, G., MORFOISSE, F., Durré, T., Blacher, S., Becker, G., Bahri, M. A., Plenevaux, A., Noël, A., & NIZET, J.-L. (2019). Contralateral vascularized lymph node transfer : an optimized mouse model. Journal of Reconstructive Microsurgery Open, 4, 83-e91.
Peer reviewed

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2019). Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value. Molecular Imaging and Biology, 21, 888-897. doi:10.1007/s11307-018-1301-0
Peer Reviewed verified by ORBi

Bastin, C., Bahri, M. A., Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (28 November 2018). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography [Paper presentation]. Belgian Molecular Imaging Community conference 'Imaging hallmarks of disease progression & treatment response', Braine-L'Alleud, Belgium.

Parmentier, E., Bahri, M. A., Plenevaux, A., Fine, M., & Estrada, J. (01 November 2018). Sound production and sonic apparatus in deep-living cusk-eels (Genypterus chilensis and Genypterus maculatus). Deep-Sea Research. Part I, Oceanographic Research Papers, 141, 83-92. doi:10.1016/j.dsr.2018.09.009
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., Salmon, E., Raedt, R., & Plenevaux, A. (18 October 2018). THE SV2A PROTEIN: IMAGING SYNAPTIC DENSITY DURING THE PROGRESSION OF THE TEMPORAL LOBE EPILEPSY IN THE KASE RAT MODEL [Poster presentation]. MINC 2018 – Multimodal Neuroimaging Cologne, Köln, Germany.

Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20th EURON PhD days, Brussels, Belgium.

Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20TH EURON PhD DAYS, Leuven, Belgium.

Serrano Navacerrada, M. E., Bartholomé, O., Van Den Ackerveken, P., Rogister, B., Tirelli, E., & Plenevaux, A. (July 2018). Decrease in SV2A expression in the hippocampus involves changes in cognition and anxiety-like features [Poster presentation]. 11th FENS Forum of Neuroscience, Berlin, Germany.

Bodart, G., Farhat, K., Charlet-Renard, J. D. C., Becker, G., Plenevaux, A., Salvatori, R., Geenen, V., & Martens, H. (06 June 2018). The severe deficiency of the somatotrope GHRH/GH/IGF1 axis of Ghrh-/- mice is associated with an important splenic atrophy and relative B lymphopenia. Frontiers in Endocrinology, 9 (Art. 296). doi:10.3389/fendo.2018.00296
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Tumor microenvironment modifications recorded with IVIM perfusion analysis after radiotherapy. Radiotherapy and Oncology, 127 (Supplement 1), 1285-S1286. doi:10.1016/S0167-8140(18)32640-9
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Brain modifications after stereotactic radiotherapy recorded by Functional MRI. Radiotherapy and Oncology, 127 (Supplement 1), 582. doi:10.1016/S0167-8140(18)31346-X
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., & Plenevaux, A. (22 March 2018). [18F]UCB-H BINDING QUANTIFICATION IN RAT BRAIN: FROM MODELLING TO SUV [Poster presentation]. 13th European Molecular Imaging Meeting - EMIM 2018, San Sebastián, Spain.

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & Martinive, P. (14 March 2018). Evaluation of tumor perfusion with IVIM analysis after radiotherapy [Paper presentation]. Fourth Symposium on small animal precision image-guided radiotherapy, Lisbonne, Portugal.

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & Martinive, P. (12 March 2018). Brain stereotactic radiotherapy damages recorded by Functional MRI [Poster presentation]. Fourth Symposium on small animal precision image-guided radiotherapy, Lisbonne, Portugal.

Becker, G., Lespine, L.-F., Bahri, M. A., Bruneel, J., Serrano Navacerrada, M. E., Luxen, A., Tirelli, E., & Plenevaux, A. (March 2018). Increased hippocampal volume in exercising mice: comparison of control conditions with in vivo voxel based morphometry [Poster presentation]. European Molecular Imaging Meeting - EMIM 2018, San Sebastian, Spain.

Parmentier, E., Boistel, R., Bahri, M. A., Plenevaux, A., & Schwarzhans, W. (March 2018). Sexual dimorphism in the sonic system and otolith morphology of Neobythites gilli (Ophidiiformes). Journal of Zoology, 305, 274-380. doi:10.1111/jzo.12561
Peer Reviewed verified by ORBi

Goux, M., Becker, G., Gorre, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., LALLEMAND, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (19 January 2018). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors [Paper presentation]. 25th NKRV Workshop, Maastricht, Netherlands.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (December 2017). Sv2a protein levels in the kainic acid epilepsy rat model during the acute phase. Epilepsia, 58 (Supplement S5), 1–S225.

Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., ... Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique.

Bahri, M. A., Plenevaux, A., Aerts, J., Bastin, C., Becker, G., Mercier, J., Valade, A., Buchanan, T., Mestdagh, N., LEDOUX, D., Seret, A., Luxen, A., & Salmon, E. (November 2017). Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 4 (4), 481-486. doi:10.1016/j.trci.2017.08.004
Peer Reviewed verified by ORBi

Goux, M., Becker, G., Gorré, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., Lallemand, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (21 August 2017). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of 2 Epidermal Growth Factor Receptor Over-Expressing Tumors. Bioconjugate Chemistry, 28 (9), 2361-2371. doi:10.1021/acs.bioconjchem.7b00374
Peer Reviewed verified by ORBi

Dammicco, S., Goux, M., Lemaire, C., Becker, G., Bahri, M. A., Plenevaux, A., Cinier, M., & Luxen, A. (2017). Regiospecific radiolabelling of Nanofitin on Ni Magnetic Beads with [18F]FBEM and in vivo PET studies. Nuclear Medicine and Biology. doi:10.1016/j.nucmedbio.2017.04.006
Peer Reviewed verified by ORBi

Manos-Turvey, A., Lemaire, C., Becker, G., Plenevaux, A., Luxen, A., Pirotte, B., & Francotte, P. (August 2017). Design and Synthesis of [18F]BPAM121, a PET-Probe Targeting AMPA-subtype Glutamatergic Receptors [Poster presentation]. EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Vienne, Austria.

Manos-Turvey, A., Lemaire, C., Becker, G., Plenevaux, A., Luxen, A., Francotte, P., & Pirotte, B. (July 2017). Synthesis of [18F]BPAM121: An AMPAR Modulator with Potential as a PET Probe [Poster presentation]. RICT 2017, Drug Discovery and Selection, 53rd International Conference on Medicinal Chemistry, Toulouse, France.

Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (26 June 2017). Pharmacokinetic characterization of [18F]UCB-H PET radiopharmaceutical in the rat brain. Molecular Pharmaceutics, 14 (8), 2719-2725. doi:10.1021/acs.molpharmaceut.7b00235
Peer Reviewed verified by ORBi

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (10 June 2017). Evaluation of dopaminergic terminal loss in a Parkinson's disease rat model, [18F]FDOPA versus [18F]FMT microPET [Paper presentation]. SNMMI 2017 Annual Meeting, Denver, United States.

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (May 2017). Comparative assessment of 6-[18F]fluoro-L-m-tyrosine and 6-[18F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson’s disease rat model. Journal of Neurochemistry, 141, 626-635. doi:10.1111/jnc.14016
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (May 2017). Following tumour microenvironment after Neoadjuvant radiotherapy with IVIM perfusion analysis. Radiotherapy and Oncology, 123 (Supplement 1), 545. doi:10.1016/S0167-8140(17)31424-X
Peer Reviewed verified by ORBi

Becker, G., Lespine, L.-F., Bahri, M. A., Luxen, A., Lemaire, C., Tirelli, E., & Plenevaux, A. (05 April 2017). Functional correlates of the protective effects of free wheel-running against cocaine psychomotor sensitization on dopamine D2 receptors: a [18F]Fallypride microPET study [Paper presentation]. European Molecular Imaging Meeting - EMIM 2017, Cologne, Germany.

Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Luxen, A., Lemaire, C., Salmon, E., & Plenevaux, A. (19 February 2017). Noninvasive quantification of [18F]UCB-H binding using microPET and population-based input function [Poster presentation]. Neuroimaging - from Molecules to Networks - TOPIM 2017, Les Houches, France.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 February 2017). Evaluating the specificity of [18F] UCB-H for the isoform SV2A, compared with isoforms SV2B and SV2C [Poster presentation]. GIGA Day 2017, Liège, Belgium.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). [18F]UCB-H RADIOTRACER AS A TOOL TO UNDERSTAND THE ROLE OF THE SV2A PROTEIN [Poster presentation]. PhD Student Day, Liège, Belgium.

Serrano Navacerrada, M. E., Bartholomé, O., Van Den Ackerveken, P., Rogister, B., Plenevaux, A., & Tirelli, E. (2017). Behavioural phenotyping of SV2A lox/lox mice: Motor and anxiety-like features [Poster presentation]. 12th National Congress of the Belgian Society for Neuroscience, Ghent, Belgium.

Maneuski, D., Giacomelli, F., Lemaire, C., Pimlott, S., Plenevaux, A., Owens, J., O'Shea, V., & Luxen, A. (2017). On the use of positron counting for radio-Assay in nuclear pharmaceutical production. Applied Radiation and Isotopes, 125, 9-14. doi:10.1016/j.apradiso.2017.03.021
Peer Reviewed verified by ORBi

Hage, S., Hubert, A., Lamair, L., Avşar, U., El Ouahabi, M., Van Daele, M., Boulvain, F., Bahri, M. A., Seret, A., & Plenevaux, A. (2017). Flow dynamics at the origin of thin clayey sand lacustrine turbidites: Examples from Lake Hazar, Turkey. Sedimentology, 64, 1929-1956. doi:10.1111/sed.12380
Peer Reviewed verified by ORBi

Lespine, L.-F., Plenevaux, A., & Tirelli, E. (2017). Study Protocol: Effect of prenatal wheel-running exercise (before and during gestation) on cocaine psychomotor sensitization expressed in the offspring in periadolescent females and males C57BL/6J mice. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/207692. doi:10.17605/OSF.IO/V6Z66

Becker, G., Lespine, L.-F., Serrano Navacerrada, M. E., Bahri, M. A., Luxen, A., Lemaire, C., Tirelli, E., & Plenevaux, A. (2017). Neuro-functional correlates of the protective effects of exercise against cocaine sensitization and dopamine D2 receptors density: a [18F]Fallypride microPET study [Paper presentation]. World Molecular Imaging Congress - WMIC 2017, Philadelphia, United States.

Salmon, E., Bahri, M. A., Manard, M., Plenevaux, A., Becker, G., Seret, A., Mella, C., Aerts, J., Giacomelli, F., Luxen, A., & Bastin, C. (2017). Decreased Synaptic Density in Early Alzheimer’s Disease Assessed with [18F]UCB-H-PET. Alzheimer's and Dementia, 13 (7), 781.
Peer reviewed

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN AN EPILEPTIC RAT MODEL [Poster presentation]. 3rd Belgium Molecular Imaging Congress (BMIC 2017), Brussels, Belgium.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN THE KAINIC ACID EPILEPSY RAT MODEL [Poster presentation]. 12th European Molecular Imaging Meeting (EMIM 2017), Cologne, Germany.

Serrano Navacerrada, M. E., Aerts, J., Bahri, M. A., Becker, G., Giacomelli, F., Lemaire, C., Luxen, A., Mercier, J., Mestdagh, N., Mievis, F., Plenevaux, A., Salmon, E., & Warnier, C. (18 November 2016). EVALUATING THE SPECIFICITY OF [18F]UCB-H FOR THE ISOFORM SV2A, COMPARED WITH ISOFORMS SV2B AND SV2C [Poster presentation]. MedChem 2016 PET & Imaging : From Chemistry Lab to Clinical Applications, Mont-Saint-Guibert, Belgium.

Plenevaux, A. (18 November 2016). In Vivo Preclinical Molecular Imaging: From the Laboratory Bench to the Patient. Pharmaceuticals, 9 (4), 73. doi:10.3390/ph9040073
Peer Reviewed verified by ORBi

BONHOMME, V., VANHAUDENHUYSE, A., Demertzi, A., Bruno, M.-A., JAQUET, O., Bahri, M. A., Plenevaux, A., Boly, M., BOVEROUX, P., Soddu, A., BRICHANT, J.-F., MAQUET, P., & LAUREYS, S. (November 2016). Resting-state Network-specific Breakdown of Functional Connectivity during Ketamine Alteration of Consciousness in Volunteers. Anesthesiology, 125 (5), 873-878. doi:10.1097/ALN.0000000000001275
Peer Reviewed verified by ORBi

Warnier, C., Lemaire, C., Becker, G., Zaragoza, G., Giacomelli, F., Aerts, J., Otabashi, M., Bahri, M. A., Mercier, J., Plenevaux, A., & Luxen, A. (06 September 2016). Enabling efficient PET imaging of Synaptic Vesicle glycoprotein 2A (SV2A) with a robust and one-step radiosynthesis of a highly potent 18F-labelled ligand ([18F]UCB-H). Journal of Medicinal Chemistry, 59, 8955-8966. doi:10.1021/acs.jmedchem.6b00905
Peer Reviewed verified by ORBi

Gijs, M., Becker, G., Plenevaux, A., Bahri, M. A., Aerts, A., Impens, N., Baatout, S., & Luxen, A. (11 August 2016). Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice. Journal of Nuclear Medicine and Radiation Therapy, 7 (5). doi:10.4172/2155-9619.1000300
Peer reviewed

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Luxen, A., Garraux, G., Lemaire, C., & Plenevaux, A. (July 2016). In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat model: comparison between [18F]FMT and [18F]FDOPA [Paper presentation]. World Molecular Imaging Congress 2015, Honolulu, United States.

Henrottin, J., Lemaire, C., Egrise, D., Zervosen, A., Van den Eynde, B., Plenevaux, A., Franci, X., Goldman, S., & Luxen, A. (June 2016). Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging. Nuclear Medicine and Biology, 43 (6), 379-389. doi:10.1016/j.nucmedbio.2016.03.001
Peer Reviewed verified by ORBi

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & MARTINIVE, P. (22 March 2016). Feasibility study of repetitive diffusion MRI after Neoadjuvant radiotherapy for following tumor microenvironment [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gend, Belgium.

Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (09 March 2016). EVALUATION OF SV2Alox/Cre TRANSGENIC MICE USING [18F]UCB-H IN VITRO AUTORADIOGRAPHY [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands.

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Luxen, A., Garraux, G., Lemaire, C., & Plenevaux, A. (08 March 2016). In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat with AAV-induced overexpression of alpha-synuclein: a [18F]FMT microPET study [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands.

Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Luxen, A., Lemaire, C., Salmon, E., & Plenevaux, A. (08 March 2016). In vivo evaluation of [18F]UCB-H binding at SV2A protein, through a new and efficient radiosynthesis of [18F]UCB-H [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands.

Bodart, G., Farhat, K., RENARD, J. D. C., Becker, G., Plenevaux, A., Martens, H., Salvatori, R., & Geenen, V. (25 January 2016). Disturbed dexamethasone-induced thymus atrophy and recovery in Ghrh-/- mice with severe deficiency of the somatotrope GHRH/GH/IGF-1 axis [Paper presentation]. GIGA-Day 2016, Liège, Belgium.

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (2016). Diffusion MRI for following tumor modifications after neoadjuvant radiotherapy. Radiotherapy and Oncology, 119, 966-S967.
Peer Reviewed verified by ORBi

MENTEN, C.* , Serrano Navacerrada, M. E.* , Bartholomé, O., Gil, J. S., Neirinckx, V., Wislet, S., Becker, G., Plenevaux, A., Van Den Ackerveken, P.* , & Rogister, B.*. (2016). Development and validation of a new mouse model to investigate the role of sv2a in epilepsy. PLoS ONE. doi:10.1371/journal.pone.0166525
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

NCHIMI LONGANG, A., Courtois, A., EL HACHEMI, M., Touat, Z., Drion, P., WITHOFS, N., Warnock, G., Bahri, M. A., Dogné, J.-M., CHERAMY-BIEN, J.-P., SCHOYSMAN, L., Joskin, J., Michel, J.-B., Defraigne, J.-O., Plenevaux, A., & SAKALIHASAN, N. (2016). Multimodality imaging assessment of the deleterious role of the intraluminal thrombus on the growth of abdominal aortic aneurysm in a rat model. European Radiology, 26, 2378-2386. doi:10.1007/s00330-015-4010-y
Peer Reviewed verified by ORBi

Bretin, F., Bahri, M. A., Luxen, A., Phillips, C., Plenevaux, A., & Seret, A. (09 September 2015). Monte Carlo simulations of the dose from imaging with GE eXplore 120 micro-CT using gate. Medical Physics, 42 (10), 5711-5719. doi:10.1118/1.4930056
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (04 September 2015). EVALUATION OF SV2Alox/Cre TRANSGENIC MOUSE USING [18F]UCB-H IN IN VITRO AUTORADIOGRAPHY [Poster presentation]. International Symposium "Aging and sleep: Perks for longevity?, Liège, Belgium.

Deverdenne, F., Claes, G., Goffin, E., Plenevaux, A., Pirotte, B., Luxen, A., & Francotte, P. (05 June 2015). Design and synthesis of PET-probes targeting AMPA-subtype receptors [Poster presentation]. 29èmes Journées franco-belges de Pharmacochimie, Spa, Belgium.

Plenevaux, A. (14 May 2015). Preclinical molecular imaging: from the laboratory bench to the patient [Paper presentation]. Joint Symposium of Liege University and Kobe University, Kobe, Japan.

Deverdenne, F., Claes, G., Goffin, E., Plenevaux, A., Pirotte, B., Luxen, A., & Francotte, P. (13 May 2015). Design and synthesis of PET-probes targeting AMPA subtype receptors [Poster presentation]. The Bioforum 2015 of BioLiège, Liège, Belgium.

Bahri, M. A., Stifkens, M., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., ... SALMON, E. (09 May 2015). [18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial. Tijdschrift voor Nucleaire Geneeskunde, 37 (3), 1457-1458.
Peer reviewed

Seret, A., Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (09 May 2015). [18F]FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model [Poster presentation]. 17th Symposium of the Belgian Society of Nuclear Medicine, Maastricht, Netherlands.

Seret, A., Bahri, M. A., Bretin, F., Luxen, A., & Plenevaux, A. (09 May 2015). Partial volume effect impact on PET preclinical dosimetry: a simulation study [Paper presentation]. 17th Symposium of the Belgian Society of Nuclear Medicine, Maastricht, Netherlands.

Dammicco, S., Lemaire, C. (Other coll.), Cinier, M. (Other coll.), Plenevaux, A. (Other coll.), & Luxen, A. (Other coll.). (May 2015). Regiospecific radiolabeling of Nanofitin on Ni Magnetic Beads with 18F-FBEM and in vivo PET studies [Poster presentation]. International Symposium on Radiophamaceutical Siences.

Henrottin, J., Lemaire, C., Zervosen, A., Egrise, D., Plenevaux, A., Doumont, G., Goldman, S., & Luxen, A. (May 2015). Fully automated radiosynthesis of 1-[18F]FETrp, a potential substrate for indoleamine 2,3-dioxygenase PET imaging [Poster presentation]. The 21st International Symposium on Radiopharmaceutical Sciences (ISRS 2015), University of Missouri, Columbia, Missouri, United States.

Goux, M., Dammicco, S. (Other coll.), Becker, G. (Other coll.), Bahri, M. A. (Other coll.), Plenevaux, A. (Other coll.), & Luxen, A. (Other coll.). (May 2015). Strategies of regioselective radiolabeling of Nanofitin binder for imaging [Poster presentation]. BioForum 2015, Liège, Belgium.

Henrottin, J., Lemaire, C., Zervosen, A., Egrise, D., Doumont, G., Plenevaux, A., Goldman, S., & Luxen, A. (02 April 2015). N1-(2-[18F]Fluoroethyl)-tryptophan: fully automated radiosynthesis, and study as potential substrate for indoleamine 2,3-dioxygenase PET imaging [Paper presentation]. La Journée-Rencontre des Jeunes Chimistes de la Société Royale de Chimie - 8ème édition, Namur, Belgium.

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (April 2015). Functional MRI for predicting metastatic spreading at the time of surgery after neoadjuvant radiotherapy. Radiotherapy and Oncology, 115 (Supplement 1), 832-S833. doi:10.1016/S0167-8140(15)41518-X
Peer Reviewed verified by ORBi

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Lemaire, C., & Plenevaux, A. (18 March 2015). 18F-FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model [Poster presentation]. European Molecular Imaging Meeting EMIM 2015, Tübingen, Germany.

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (27 January 2015). Identification of predictive markers based on functional imaging of metastatic spreading at the time of surgery after neoadjuvant radiotherapy [Poster presentation]. Giga day 2015, Liège, Belgium.

Tarragon Cros, E., Ferrara, A., Tirelli, E., Bahri, M. A., Plenevaux, A., & Garraux, G. (27 January 2015). Effects of α-synuclein levels on cerebral synaptic function: Validation of a novel PET radioligand for the early diagnosis of Parkinson’s disease [Poster presentation]. 2015 GIGA day, Liège, Belgium.

Bahri, M. A., Stifkens, M., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., ... SALMON, E. (27 January 2015). [18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial [Poster presentation]. 2015 GIGA day, Liège, Belgium.

Moës, F., Plenevaux, A., Becker, G., Tirelli, E., & Lespine, L.-F. (27 January 2015). Exploration of volumetric cerebral changes, with de micro-MRi, due to psychomotor exercise in mice [Poster presentation]. GIGA day, Liège, Belgium.

Bretin, F., Bahri, M. A., BERNARD, C., Warnock, G., Aerts, J., Mestdagh, N., Buchanan, T., Otoul, C., Koestler, F., Mievis, F., Giacomelli, F., Degueldre, C., Hustinx, R., Luxen, A., Seret, A., Plenevaux, A., & Salmon, E. (17 January 2015). Biodistribution and radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H: First-in-human study. Molecular Imaging and Biology, 17, 557-564. doi:10.1007/s11307-014-0820-6
Peer Reviewed verified by ORBi

Henrottin, J., Zervosen, A., Lemaire, C., Sapunaric, F., Laurent, S., Van den Eynde, B., Goldman, S., Plenevaux, A., & Luxen, A. (January 2015). N1-Fluoroalkyltryptophan analogues: synthesis and in vitro study as potential substrates for indoleamine 2,3-dioxygenase. ACS Medicinal Chemistry Letters, 6, 260-265. doi:10.1021/ml500385d
Peer Reviewed verified by ORBi

Warnock, G., Aerts, J., Bahri, M. A., Bretin, F., Lemaire, C., Giacomelli, F., Mievis, F., Mestdagh, N., Buchanan, T., Valade, A., Mercier, J., Wood, M., Gillard, M., Seret, A., Luxen, A., SALMON, E., & Plenevaux, A. (01 August 2014). Evaluation of [18F]UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain. Journal of Nuclear Medicine, 55 (8), 1336-1341. doi:10.2967/jnumed.113.136143
Peer Reviewed verified by ORBi

Bahri, M. A., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., Plenevaux, A., & Salmon, E. (06 June 2014). [18F]UCB-H AS A NEW PET RADIOTRACER FOR SYNAPTIC VESICLE PROTEIN 2A [Poster presentation]. European Molecular Imaging Meeting - EMIM 2014, Antwerp, Belgium.

Deverdenne, F., Goffin, E., Plenevaux, A., Pirotte, B., Luxen, A., & Francotte, P. (05 June 2014). Design and synthesis of high-affinity ligands of AMPA receptors and study of their Fluorine-18 radiolabeling [Poster presentation]. 28èmes Journées franco-belges de Pharmacochimie, Metz, France.

Henrottin, J., Zervosen, A., Lemaire, C., Sapunaric, F., Laurent, S., Galleni, M., Van den Eynde, B., Goldman, S., Plenevaux, A., & Luxen, A. (June 2014). Synthesis of N-fluoroalkyl-tryptophan and study of their biological activity as potential substrates for indoleamine 2,3-dioxygenase [Poster presentation]. French-American Chemical society Symposium - FACS XV.

Bahri, M. A., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Mievis, F., Léonard, M., Seret, A., Luxen, A., Plenevaux, A., & Salmon, E. (27 May 2014). [18F]UCB-H AS A BRAIN SV2A RADIOTRACER: A FIRST CLINICAL TRIAL [Poster presentation]. XIII Turku PET Symposium, Turku, Finland.

Bretin, F., Mauxion, T., Warnock, G., Bahri, M. A., Libert, L., Lemaire, C., Luxen, A., Bardies, M., Seret, A., & Plenevaux, A. (May 2014). Hybrid MicroPET Imaging for Dosimetric Applications in Mice: Improvement of Activity Quantification in Dynamic MicroPET Imaging for Accelerated Dosimetry Applied to 6-[ 18 F] Fluoro- L -DOPA and 2-[ 18 F]Fluoro- L -Tyrosine. Molecular Imaging and Biology, 16 (3), 383-394. doi:10.1007/s11307-013-0706-z
Peer Reviewed verified by ORBi

Denoël, T., Zervosen, A., Lemaire, C., Plenevaux, A., & Luxen, A. (2014). Synthesis of protected α-alkyl lanthionine derivatives. Tetrahedron, 70 (30), 4526 - 4533. doi:10.1016/j.tet.2014.05.004
Peer Reviewed verified by ORBi

Bretin, F., Warnock, G., Luxen, A., Plenevaux, A., Seret, A., & Bahri, M. A. (October 2013). Performance evaluation and X-ray dose quantification for various scanning protocols of the GE eXplore 120 micro-CT. IEEE Transactions on Nuclear Science, 60 (5), 3235-3241. doi:10.1109/TNS.2013.2279180
Peer Reviewed verified by ORBi

Warnock, G., Turtoi, A., Blomme, A., Bretin, F., Bahri, M. A., Lemaire, C., Libert, L., Seret, A., Luxen, A., Castronovo, V., & Plenevaux, A. (22 August 2013). In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: A new tool for oncology and radiotracer development. Journal of Nuclear Medicine, 54 (10), 1782-1788. doi:10.2967/jnumed.112.117150
Peer Reviewed verified by ORBi

Libert, L., Franci, X., Plenevaux, A., OOi, T., Maruoka, K., Luxen, A., & Lemaire, C. (July 2013). Production at the Curie Level of No-Carrier-Added 6-18F-Fluoro-L-Dopa. Journal of Nuclear Medicine, 54 (7), 1154-1161. doi:10.2967/jnumed.112.112284
Peer Reviewed verified by ORBi

Bretin, F., Warnock, G., Bahri, M. A., Aerts, J., Mestdagh, N., Buchanan, T., Valade, A., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., Salmon, E., Seret, A., & Plenevaux, A. (07 May 2013). Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H. EJNMMI Research, 3 (1), 35. doi:10.1186/2191-219X-3-35
Peer Reviewed verified by ORBi

Libert, L., Lemaire, C., Giacomelli, F., Léonard, M., Plenevaux, A., Franci, X., & Luxen, A. (May 2013). Quality controls of no-carrier-added aromatic amino acids such as FDOPA and FTYR produced at curie level [Poster presentation]. The 20th International Symposium on Radiopharmaceutical Science, Jeju, South Korea.

Warnock, G., Aerts, J., Mestdagh, N., Valade, A., Mercier, J., Buchanan, T., Plenevaux, A., & Luxen, A. (2013). Evaluation of a new [18F] labeled tracer targeting synaptic vesicle protein 2C by ex vivo autoradiography and in vivo PET study in rat brain [Poster presentation]. European Molecular Imaging Meeting EMIM 2013.

Bretin, F., Mauxion, T., Bahri, M. A., Luxen, A., Plenevaux, A., Bardies, M., & Seret, A. (2013). Absorbed doses to mice for three [18F]-tracers calculated from experimental kinetic data and Monte Carlo simulations [Poster presentation]. Annual Congress of the European Association of Nuclear Medicine 2013, Lyon, France.

Aerts, J., Otabashi, M., Giacomelli, F., Warnock, G., Bahri, M. A., Bretin, F., Sauvage, X., Thielen, C., Lemaire, C., Salmon, E., Plenevaux, A., & Luxen, A. (2013). Radiosynthesis and first small animal microPET imaging of [18F]UCB-H, a new fluorine-18 labelled tracer targeting synaptic vesicle protein 2A (SV2A) [Paper presentation]. 26th Annual Congress of the EANM.

Bahri, M. A., Bretin, F., Warnock, G., Luxen, A., Salmon, E., Plenevaux, A., & Seret, A. (03 November 2012). Performance Evaluation of the GE eXplore CT 120 Micro-CT for Various Scanning Protocols [Poster presentation]. IEEE 2012 Nuclear Science Symposium and Medical Imaging Conference, Anaheim, California, United States. doi:10.1109/NSSMIC.2012.6551868

Bretin, F., Warnock, G., Bahri, M. A., Libert, L., Lemaire, C., Phillips, C., Plenevaux, A., Luxen, A., & Seret, A. (October 2012). Dosimetry for 6-[18F]Fluoro-L-DOPA in Humans Based on Biodistribution in Mice [Poster presentation]. EANM'12 Annual Congress of the European Association of Nuclear Medicine, Milano, Italy.

Warnock, G., Turtoi, A., Blomme, A., Gonzalez, A., Bretin, F., Bahri, M. A., Lemaire, C., Seret, A., Castronovo, V., Luxen, A., & Plenevaux, A. (October 2012). In Ovo PET Imaging Of A Human Colorectal Carcinoma Model In Chicken Chorioallantoic Membrane [Poster presentation]. Annual Congress of the European Association of Nuclear Imaging, Milan, Italy.

Taleb, D., Bahri, M. A., Seret, A., Warnock, G., Salmon, E., Luxen, A., Plenevaux, A., & Anizan, N. (17 September 2012). Performance Measurements of the microPET FOCUS 120 for Iodine-124 Imaging. IEEE Transactions on Nuclear Science, 59 (5), 1868-1878. doi:10.1109/TNS.2012.2205402
Peer Reviewed verified by ORBi

Bretin, F., Warnock, G., Bahri, M. A., Libert, L., Lemaire, C., Phillips, C., Seret, A., Luxen, A., & Plenevaux, A. (September 2012). Dosimetry for 6-[18F]Fluoro-L-DOPA in humans based on in vivo microPET scans and ex vivo tissue distribution in mice [Poster presentation]. World Molecular Imaging Congress, Dublin, Ireland.

Bahri, M. A., Tombuloglu, S., Warnock, G., Taleb, D., Bretin, F., Degueldre, C., Luxen, A., Salmon, E., Plenevaux, A., Comtat, C., & Seret, A. (September 2012). Small animal imaging with human PET [Poster presentation]. World Molecular Imaging Congress, Dublin, Ireland.

Warnock, G., Aerts, J., Bahri, M. A., Bretin, F., Buchanan, T., Klitgaard, H., Mestdagh, N., Valade, A., Mercier, J., Seret, A., Luxen, A., SALMON, E., & Plenevaux, A. (September 2012). CHARACTERIZATION OF A NOVEL RADIOTRACER TARGETING SYNAPTIC VESICLE PROTEIN 2A (SV2A) [Poster presentation]. World Molecular Imaging Congress, Dublin, Ireland.

Warnock, G., Bahri, M. A., Bretin, F., Seret, A., Luxen, A., & Plenevaux, A. (September 2012). PET In Conscious Rodents - Quantification of Stress During The Training Process [Poster presentation]. World Molecular Imaging Congress, Dublin, Ireland.

Bahri, M. A., Warnock, G., Taleb, D., Bretin, F., Luxen, A., Salmon, E., Plenevaux, A., & Seret, A. (September 2012). MicroPET Focus 120 scanner use at high-­‐count rate [Poster presentation]. World Molecular Imaging Congress, Dublin, Ireland.

Blomme, A., Turtoi, A., Delvaux, D., Patsos, G., Somja, J., Debois, D., Delvenne, P., Warnock, G., Plenevaux, A., Luxen, A., Drion, P., DETRY, O., De Pauw, E., & Castronovo, V. (2012). Imaging Guided Proteomics Unveils Heterogeniety in Colorectal Carcinoma Liver Metastases – Implications for Targeted Therapies. In Proceedings Giga Day 2012.

Lemaire, C., Libert, L., Plenevaux, A., Aerts, J., Franci, X., & Luxen, A. (24 March 2012). Fast and reliable method for the preparation of ortho- and para-[18F]fluorobenzyl halide derivatives: Key intermediates for the preparation of no-carrier-added PET aromatic radiopharmaceuticals. Journal of Fluorine Chemistry, 138, 48-55. doi:10.1016/j.jfluchem.2012.03.015
Peer Reviewed verified by ORBi

Taleb, D., Bahri, M. A., Warnock, G., Salmon, E., Luxen, A., Plenevaux, A., & Seret, A. (2012). NEMA NU4-2008 Performance Evaluation for the MicroPET FOCUS 120 and Iodine-124. In IEEE proceedings of ANIMMA 2011. IEEE Catalogue.
Peer reviewed

Bahri, M. A., Warnock, G., Plenevaux, A., Choquet, P., Constantinesco, A., Salmon, E., Luxen, A., & Seret, A. (21 August 2011). Performance evaluation of the General Electric eXplore CT 120 micro-CT using the vmCT phantom. Nuclear Instruments and Methods in Physics Research. Section A, Accelerators, Spectrometers, Detectors and Associated Equipment, 648, 181-S185. doi:10.1016/j.nima.2010.11.178
Peer Reviewed verified by ORBi

Warnock, G., Bahri, M. A., Goblet, D., Giacomelli, F., Lemaire, C., Aerts, J., Seret, A., Langlois, X., Luxen, A., & Plenevaux, A. (10 August 2011). Use of a beta microprobe system to measure arterial input function in PET via an arteriovenous shunt in rats. EJNMMI Research, 1, 13. doi:10.1186/2191-219X-1-13
Peer Reviewed verified by ORBi

Bahri, M. A., Taleb, D., Warnock, G., Salmon, E., Plenevaux, A., & Seret, A. (29 May 2011). NEMA NU4-2008 PERFORMANCE EVALUATION FOR THE MICROPET FOCUS 120 AND IODINE-124 [Poster presentation]. XII PET Symposium, Turku, Finland.

Taleb, D., Bahri, M. A., Warnock, G., Plenevaux, A., Salmon, E., & Seret, A. (07 May 2011). Evaluation des performances du microPET Siemens FOCUS 120 pour l’Iode 124 en utilisant la norme NEMA NU4-2008 [Poster presentation]. Congrès franco-belgo-luxembourgeois de médecine nucléaire, Luxembourg ville, Luxembourg.

Geuzaine, A., Bahri, M. A., Warnock, G., Goblet, D., Tirelli, E., Lemaire, C., Seret, A., Salmon, E., Garraux, G., Luxen, A., & Plenevaux, A. (May 2011). Reliability in kinetic modeling of [18F]fallypride binding in the mouse brain: application of test-retest method [Poster presentation]. XII Turku PET symposium, Turku, Finland.

Bahri, M. A., Geuzaine, A., Warnock, G., Goblet, D., Tirelli, E., Lemaire, C., Seret, A., Salmon, E., Luxen, A., & Plenevaux, A. (17 January 2011). [18F]fallypride binding in the mouse brain: test-retest and effects of registration [Paper presentation]. Hot Topics in Molecular Imaging 2011 (TOPIM 2011) - The 5th Winter Conference of the European Society for Molecular Imaging, Les Houches, France.

Bahri, M. A., Warnock, G., Taleb, D., Plenevaux, A., Luxen, A., Salmon, E., & Seret, A. (17 January 2011). Image Quality evaluation for 124I in the microPET Focus 120 scanner using the NEMA NU4-2008 phantom [Paper presentation]. Hot Topics in Molecular Imaging 2011 (TOPIM 2011) - The 5th Winter Conference of the European Society for Molecular Imaging, Les Houches, France.

Dedeurwaerdere, S., Wintmolders, C., Straetemans, R., Warnock, G., Plenevaux, A., & Langlois, X. (17 November 2010). Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: Exemplified by an mGlu2/3 receptor agonist. Society-for-Neuroscience Abstracts/Annual Meeting Publications, 40, 767.8/X18.
Peer reviewed

Warnock, G., Dedeurwaerdere, S., Bahri, M. A., Goblet, D., Lemaire, C., Giacomelli, F., Langlois, X., Luxen, A., & Plenevaux, A. (September 2010). IN VIVO PET IMAGING OF THE EFFECT OF THE NMDA ANTAGONIST MEMANTINE ON GLUCOSE METABOLISM IN THE RODENT BRAIN [Poster presentation]. 2010 World Molecular Imaging Congress, Kyoto, Japan.

Warnock, G., Bahri, M. A., Goblet, D., Lemaire, C., Giacomelli, F., Langlois, X., Luxen, A., & Plenevaux, A. (September 2010). THE EFFECT OF P-GP BLOCKADE ON THE BINDING OF 18F-FALLYPRIDE TO DOPAMINE RECEPTORS IN THE RAT BRAIN [Poster presentation]. 2010 World Molecular Imaging Congress, Kyoto, Japan.

Warnock, G., Bahri, M. A., Goblet, D., Lemaire, C., Giacomelli, F., Langlois, X., Luxen, A., & Plenevaux, A. (September 2010). Kinetic modelling of 18F-fallypride binding to dopamine receptors – a comparison between beta microprobe and microPET [Poster presentation]. 2010 World Molecular Imaging Congress, Kyoto, Japan.

Warnock, G., Dedeurwaardere, S., Bahri, M. A., Goblet, D., Lemaire, C., Giacomelli, F., Langlois, X., Luxen, A., & Plenevaux, A. (September 2010). THE EFFECT OF BETA MICROPROBE IMPLANTATION ON THE BLOOD BRAIN BARRIER [Poster presentation]. 2010 World Molecular Imaging Congress, Kyoto, Japan.

Kaisin, G., Flagothier, J., Mercier, F., Thonon, D., Paris, J., Kech, C., Lemaire, C., Plenevaux, A., & Luxen, A. (June 2010). Click chemistry : radiolabelling of oligonucleotides with fluorine- 18 for PET [Poster presentation]. FACS XIII - French American Chemical Society, Obernai, France.

Goblet, D., Thonon, D., Plenevaux, A., Lemaire, C., Defraiteur, C., Wouters, L., Franci, X., & Luxen, A. (30 May 2010). Automated radiosynthesis of [18F]MPPF derivatives for imaging 5-HT1A receptors [Poster presentation]. 5TH European Molecular Imaging Meeting, Warsaw, Poland.

Flagothier, J., Mercier, F., Kaisin, G., Teller, N., Warnock, G., Plenevaux, A., & Luxen, A. (2010). A general method for labeling siRNA by click chemistry with fluorine-18 for in vivo PET imaging [Poster presentation]. Journee du departement du chimie, Liege, Belgium.

Aerts, J., Voccia, S., Lemaire, C., Giacomelli, F., Goblet, D., Thonon, D., Plenevaux, A., Warnock, G., & Luxen, A. (2010). Fast production of highly concentrated reactive [18F] fluoride for aliphatic and aromatic nucleophilic radiolabelling. Tetrahedron Letters, 51, 64-66. doi:10.1016/j.tetlet.2009.10.085
Peer Reviewed verified by ORBi

Lemaire, C., Aerts, J., Voccia, S., Libert, L., Mercier, F., Goblet, D., Plenevaux, A., & Luxen, A. (2010). Fast Production of Highly Reactive No-Carrier-Added [18F]Fluoride for the Labeling of Radiopharmaceuticals. Angewandte Chemie International Edition, 49, 1-5. doi:10.1002/anie.200906341
Peer Reviewed verified by ORBi

Boveroux, P., Vanhaudenhuyse, A., Bruno, M.-A., Noirhomme, Q., Lauwick, S., Luxen, A., Degueldre, C., Plenevaux, A., Schnakers, C., Phillips, C., Brichant, J.-F., Bonhomme, V., Maquet, P., Greicius, M. D., Laureys, S., & Boly, M. (2010). Breakdown of within- and between-network resting state functional magnetic resonance imaging connectivity during propofol-induced loss of consciousness. Anesthesiology, 113 (5), 1038-53. doi:10.1097/ALN.0b013e3181f697f5
Peer Reviewed verified by ORBi

Warnock, G., Lemaire, C., Langlois, X., Luxen, A., & Plenevaux, A. (October 2009). Accurate measurement of arterial input function during FDG PET using a beta microprobe. Journal of Cerebral Blood Flow and Metabolism, 29 (S1), 339-S339.
Peer Reviewed verified by ORBi

Bahri, M. A., Plenevaux, A., Warnock, G., Luxen, A., & Seret, A. (October 2009). NEMA NU4-2008 Image Quality Performance Report for the microPET Focus 120 and for Various Transmission and Reconstruction Methods. Journal of Nuclear Medicine, 50, 1730-1738. doi:10.2967/jnumed.109.063974
Peer Reviewed verified by ORBi

Warnock, G., Goblet, D., Lemaire, C., Giacomelli, F., Bahri, M. A., Langlois, X., Luxen, A., & Plenevaux, A. (October 2009). DISPLACEMENT OF 18F-FALLYPRIDE BINDING WITH HALOPERIDOL IN A WITHIN-SUBJECT DESIGN USING A BETA MICROPROBE. Journal of Cerebral Blood Flow and Metabolism, 29 (S1), 352-S353.
Peer Reviewed verified by ORBi

Bahri, M. A., Warnock, G., Goblet, D., Lemaire, C., Langlois, X., Seret, A., Luxen, A., & Plenevaux, A. (12 July 2009). Comparaison of reference tissue model versus two compartement model with input function for [18F]Fallypride modelling. A combined microPET-Beta microprobe study in rat. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 108.
Peer Reviewed verified by ORBi

Libert, L., Lemaire, C., Wouters, L., Plenevaux, A., Franci, X., & Luxen, A. (July 2009). Large Scale Preparation of [18]Fluoromethoxybenzyl Bromides, Key Precursors for 2-[18F]Fluoro-L-Tyrosine and 6-[18F]Fluoro-L-Dopa. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 292.
Peer Reviewed verified by ORBi

Aerts, J., Lemaire, C., Plenevaux, A., & Luxen, A. (July 2009). Are Ionic Liquid Useful for Fluorine-18 Labeling? Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 193.
Peer Reviewed verified by ORBi

Warnock, G., Goblet, D., Lemaire, C., Giacomelli, F., Bahri, M. A., Langlois, X., Luxen, A., & Plenevaux, A. (July 2009). TIME-DEPENDENT PREFERENTIAL IN VIVO D2 OCCUPANCY BY AMISULPRIDE IN THE MEDIAL STRIATUM – CONTINUOUS MEASUREMENT USING A BETA MICROPROBE SYSTEM. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 105.
Peer Reviewed verified by ORBi

Warnock, G., Goblet, D., Lemaire, C., Giacomelli, F., Bahri, M. A., Langlois, X., Luxen, A., & Plenevaux, A. (July 2009). THE USEFULNESS OF AN ARTERIOVENOUS SHUNT COMBINED WITH A BETA MICROPROBE FOR THE MEASUREMENT OF INPUT FUNCTION IN RATS. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 106.
Peer Reviewed verified by ORBi

Libert, L., Lemaire, C., Denoël, T., Plenevaux, A., Aerts, J., & Luxen, A. (July 2009). New Improvements in the Enantioselective Synthesis of 2-[18F]Fluoro-L-Tyrosine and 6-[18F]Fluoro-L-Dopa. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 196.
Peer Reviewed verified by ORBi

Lemaire, C., Aerts, J., Voccia, S., Plenevaux, A., & Luxen, A. (July 2009). Use of Organic Bases for 18F-Fluoride Anion Exchange Elution avoiding the Classical Azeotropic drying Step Before Labeling. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 198.
Peer Reviewed verified by ORBi

Lemaire, C., Libert, L., Plenevaux, A., & Luxen, A. (July 2009). Fast and Reliable Method for the Preparation of Various [18F]Fluorobenzyl Halides. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 178.
Peer Reviewed verified by ORBi

Aerts, J., Voccia, S., Lemaire, C., Thonon, D., Plenevaux, A., & Luxen, A. (July 2009). Tertiary Alcohols to Avoid Evaporation in Fluorine-18 Labeling. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 204.
Peer Reviewed verified by ORBi

Warnock, G., Goblet, D., Lemaire, C., Giacomelli, F., Bahri, M. A., Langlois, X., Luxen, A., & Plenevaux, A. (July 2009). USE OF A BETA MICROPROBE SYSTEM AS AN AFFORDABLE TRANSLATIONAL TOOL COMPARED TO PET – EXAMPLES USING FDG AND 18F-FALLYPRIDE BINDING. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 55.
Peer Reviewed verified by ORBi

Aerts, J., Voccia, S., Lemaire, C., Giacomelli, F., Goblet, D., Thonon, D., Plenevaux, A., & Luxen, A. (July 2009). Modified Non-Ionic Solid Supports: a Way to High Activity Fluorine-18 Radiochemistry in Microfluidic Devices. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 12.
Peer Reviewed verified by ORBi

Kaisin, G., Flagothier, J., Mercier, F., Thonon, D., Paris, J., Kech, C., Lemaire, C., Plenevaux, A., & Luxen, A. (18 March 2009). Click chemistry : radiolabelling of oligonucleotides with fluorine-18 for PET imaging [Poster presentation]. Learning Organic Synthesis Tremendously (LOST II), Namur, Belgium.

Flagothier, J., Mercier, F., Kaisin, G., Lemaire, C., Plenevaux, A., & Luxen, A. (21 January 2009). Synthesis of an universal linker to label oligonucleotides via Click Chemistry [Poster presentation]. Journées rencontres des jeunes chimistes, Wépion, Belgium.

Aerts, J., Plenevaux, A., Lemaire, C., Giacomelli, F., Warnock, G., Phillips, C., & Luxen, A. (07 November 2008). Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats. BMC Medical Physics, 8, 4. doi:10.1186/1756-6649-8-4
Peer Reviewed verified by ORBi

Bahri, M. A., Plenevaux, A., & Seret, A. (October 2008). Image Quality, Accuracy of Attenuation and Scatter Corrections of the microPET Focus 120 Using the NEMA NU4-2008 Phantom [Poster presentation]. IEEE Nuclear Science Symposium and Medical Imaging Conference Dresden 2008, Dresden, Germany.

Goblet, D., Lemaire, C., Giacomelli, F., Plenevaux, A., Warnock, G., Franci, X., Wouters, L., & Luxen, A. (September 2008). Automated synthesis of [18F]fallypride for imaging dopamine D2 receptors [Poster presentation]. World Molecular Imaging Congress, Nice, France.

Thonon, D., Flagothier, J., Paris, J., Mercier, F., Kaisin, G., Kech, C., Lemaire, C., Plenevaux, A., & Luxen, A. (August 2008). 18F LABELING OF BIOMOLECULES USING CLICK CHEMISTRY FOR PET APPLICATIONS : SYNTHETIC DEVELOPMENTS. Drugs of the Future, 33 (A), 235.
Peer reviewed

Bonhomme, V., Maquet, P., Phillips, C., Plenevaux, A., Hans, P., Luxen, A., Lamy, M., & Laureys, S. (March 2008). The Effect of Clonidine Infusion on Distribution of Regional Cerebral Blood Flow in Volunteers. Anesthesia and Analgesia, 106 (3), 899-909. doi:10.1213/ane.0b013e3181619685
Peer Reviewed verified by ORBi

Lacan, G., Plenevaux, A., Rubins, D. J., Way, B. M., Defraiteur, C., Lemaire, C., Aerts, J., Luxen, A., Cherry, S. R., & Melega, W. P. (2008). Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies. European Journal of Nuclear Medicine and Molecular Imaging, 35 (12), 2256-66. doi:10.1007/s00259-008-0832-z
Peer Reviewed verified by ORBi

Bahri, M. A., Plenevaux, A., & Seret, A. (2008). Attenuation and scatter correction accuracy of the microPET Focus 120 assessed with the NEMA NU-4 2008 phantom. European Journal of Nuclear Medicine and Molecular Imaging, 35 (S2), 193.
Peer Reviewed verified by ORBi

Defraiteur, C., Plenevaux, A., Scuvée-Moreau, J., Rouchet, N., Goblet, D., Luxen, A., & Seutin, V. (November 2007). Characterization of 4-(2-hydroxyphenyl)-1-[2 '-[N-(2 ''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist. British Journal of Pharmacology, 152 (6), 952-958. doi:10.1038/sj.bjp.0707431
Peer Reviewed verified by ORBi

Plenevaux, A. (2007). Contribution au développement de composés radiopharmaceutiques pour l'étude de la neurotransmission sérotoninergique en tomographie à émission de positons [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/66509

Lecomte, F., Aerts, J., Plenevaux, A., Lignon, S., Chapuis-Hugon, F., Chiap, P., Crommen, J., Luxen, A., Pichon, V., & Hubert, P. (September 2007). PPERFORMANCE EVALUATION OF TWO MIPS FOR THE SPE-LC-UV DETERMINATION OF p-[18F]MPPF IN PLASMA [Poster presentation]. RDPA 2007, 12th Internatioinal Meeting on Recent Developments in Pharmaceutical Analysis, Island of Elba, Italy.

Lecomte, F., Aerts, J., Plenevaux, A., Lignon, S., Denjean, C., Chapuis-Hugon, F., Chiap, P., Crommen, J., Luxen, A., Pichon, V., & Hubert, P. (June 2007). DEVELOPMENT AND VALIDATION OF A METHOD FOR THE LC DETERMINATION p-[18F]MPPF IN PLASMA USING A MISPE [Poster presentation]. HPLC 2007 - 31st International Symposium on High Performance Liquid Phase Separations and Related Techniques, Ghent, Belgium.

Mercier, F., Zervosen, A., Lemaire, C., Plenevaux, A., Joris, B., & Luxen, A. (22 March 2007). Synthesis of anhydro-muramic acid derivatives as substrates for MurNAc amidase [Poster presentation]. Biomedica, Aachen, Germany.

Lecomte, F., Aerts, J., Houbart, V., Plenevaux, A., Lignon, S., Chiap, P., Crommen, J., Luxen, A., Pichon, V., & Hubert, P. (2007). EVALUATION DE DEUX POLYMERES A EMPREINTES MOLECULAIRES POUR LE DOSAGE DU p-[18F]MPPF DANS LE PLASMA [Poster presentation]. 7ème congrès francophone de l'AfSep sur les sciences séparatives et les couplages - SEP07, Grenoble, France.

Vanhaudenhuyse, A., Bruno, M.-A., Brédart, S., Plenevaux, A., & Laureys, S. (2007). The challenge of disentangling reportability and phenomenal consciousness in post-comatose states. Behavioral and Brain Sciences, 30 (5-6), 529-530. doi:10.1017/S0140525X0700310X
Peer Reviewed verified by ORBi

Lecomte, F., Aerts, J., Plenevaux, A., Lignon, S., Haber, G., Boulanger, B., Chiap, P., Luxen, A., & Hubert, P. (September 2006). EVALUATION OF MOLECULARLY IMPRINTED POLYMERS BY MEANS OF EXPERIMENTAL DESIGN PRIOR TO THE DETERMINATION OF p-[18F]MPPF IN PLASMA [Poster presentation]. MIP2006 - Fourth International Workshop on Molecularly Imprinted Polymers, Cardiff, United Kingdom.

Defraiteur, C., Lemaire, C., Luxen, A., & Plenevaux, A. (July 2006). Radiochemical synthesis and tissue distribution of p-[F-18]DMPPF, a new 5-HT1A ligand for PET, in rats. Nuclear Medicine and Biology, 33 (5), 667-675. doi:10.1016/j.nucmedbio.2006.03.010
Peer Reviewed verified by ORBi

Mercier, F., Lemaire, C., Plenevaux, A., Nguyen-Distèche, M., Zervosen, A., Joris, B., & Luxen, A. (17 May 2006). Synthesis of anhydro-muramic acid derivatives as substrates for MurNAc amidase [Poster presentation]. Bioforum 2006.

Giacomelli, F., Luxen, A., Lemaire, C., & Plenevaux, A. (03 February 2006). DEVELOPPEMENT D'INHIBITEURS SELECTIFS DE LA TRYPTOPHANE HYDROXYLASE [Paper presentation]. 7 èmes Rencontres Franco-Belges de chimie organique, Houffalize, Belgium.

Plenevaux, A. (25 November 2005). P-glycoprotein, the gatekeeper: influence on the tissue distribution of the 5-HT1a antagonist p-[18F]MPPF, an ex vivo study in rats [Paper presentation]. MedChem 05. Targeting the Brain, Successes and Pitfalls. Annual One-Day Meeting on Medicinal Chemistry of SRC & KVCV, Namur, Belgium.

Mercier, F., Lemaire, C., Plenevaux, A., Nguyen, M., Zervosen, A., Joris, B., & Luxen, A. (10 October 2005). Synthesis of anhydro-muranic acid derivatives as substrates for MurNAc amidase [Poster presentation]. 9. International SFB-Symposium. Asymmetric Synthesis with Chemical and Biological Methods, Aachen, Germany.

Teller, N., Lemaire, C., Plenevaux, A., Nguyen, M., Zervosen, A., Joris, B., & Luxen, A. (10 October 2005). Synthesis of protected meso-diaminopimelic acid [Poster presentation]. 9. International SFB-Symposium. Asymmetric Synthesis with Chemical and Biological Methods, Aachen, Germany.

Kech, C., Lemaire, C., Brichard, L., Plenevaux, A., & Luxen, A. (2005). New Methods For Halogenation of [18F]Fluorinated Benzyl Derivatives. Journal of Labelled Compounds and Radiopharmaceuticals, 48, 30.
Peer Reviewed verified by ORBi

Defraiteur, C., Lemaire, C., Luxen, A., & Plenevaux, A. (2005). Radiochemical Synthesis of OCH2F-[18F]MPPF a New Analogue of p-[18F]MPPF for the Study of 5-HT1A Receptors. Journal of Labelled Compounds and Radiopharmaceuticals, 48, 102.
Peer Reviewed verified by ORBi

Defraiteur, C., Lemaire, C., Luxen, A., & Plenevaux, A. (2005). Ex Vivo Evaluation of p-[18F]D-MPPF for the Study of 5-HT1A Receptors. Journal of Labelled Compounds and Radiopharmaceuticals, 48, 75.
Peer Reviewed verified by ORBi

Giacomelli, F., Lemaire, C., Plenevaux, A., & Luxen, A. (17 November 2004). Mise au point de sondes pour l'étude du système sérotoninergique par Tomographie à Emission de Positons (TEP) [Poster presentation]. The 2004 Lilly European Distinguished Lectureship, Namur, Belgium.

Lemaire, C., Gillet, S., Guillouet, S., Plenevaux, A., Aerts, J., & Luxen, A. (2004). Highly enantioselective synthesis of no-carrier-added 6-[18F]Fluoro-L-dopa by chiral phase-transfer alkylation. European Journal of Organic Chemistry, (13), 2899-2904. doi:10.1002/ejoc.200400059
Peer Reviewed verified by ORBi

Defraiteur, C., Muroni, S., Lemaire, C., Luxen, A., & Plenevaux, A. (2004). Tissue distribution and metabolism of D-p-[18F]MPPF in rats [Paper presentation]. Society of Nuclear Medicine, 51th Annual Meeting, Philadelphia, United States.

Defraiteur, C., Plenevaux, A., Lemaire, C., & Luxen, A. (August 2003). Radiochemical Synthesis of p-[18F]Desmethyl-MPPF (p-[18F]D-MPPF) for the Study of 5-HT1A Receptors. Journal of Labelled Compounds and Radiopharmaceuticals, 46 (S1), 157.
Peer Reviewed verified by ORBi

Giacomelli, F., Lemaire, C., Plenevaux, A., & Luxen, A. (13 June 2003). Mise au point de sondes pour l'étude du système sérotoninergique par tomographie à émission de positons (TEP) [Poster presentation]. 5 èmes Rencontres Franco-Belges de chimie organique, Houffalize, Belgium.

Otabashi, M., Giacomelli, F., Lemaire, C., Plenevaux, A., & Luxen, A. (13 June 2003). Radiosynthèse de dérivés du 7-[18F]fluoroindole [Poster presentation]. 5 èmes Rencontres Franco-Belges de chimie organique, Houffalize, Belgium.

Defraiteur, C., Plenevaux, A., Lemaire, C., & Luxen, A. (13 June 2003). Radiosynthèses d'antagonistes des récepteurs 5-HT1A [Poster presentation]. 5ème Rencontres Franco-Belges de chimie organique, Houffalize, Belgium.

Rubins, D. J., Melega, W. P., Lacan, G., Way, B., Plenevaux, A., Luxen, A., & Cherry, S. R. (2003). Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain. NeuroImage, 20 (4), 2100-18. doi:10.1016/j.neuroimage.2003.07.011
Peer Reviewed verified by ORBi

Brichard, L., Del Fiore, G., Lemaire, C., Plenevaux, A., & Luxen, A. (2003). Simple device for the radiosynthesis of [carbonyl-11C]amides, esters and ketones using carbon-11 monoxide. Journal of Labelled Compounds and Radiopharmaceuticals, 46, 74.
Peer Reviewed verified by ORBi

Otabashi, M., Giacomelli, F., Lemaire, C., Plenevaux, A., & Luxen, A. (2003). Radiosynthesis of 7-[18F]fluoroindole derivatives. Journal of Labelled Compounds and Radiopharmaceuticals, 46, 223.
Peer Reviewed verified by ORBi

Wouters, L., Lemaire, C., Plenevaux, A., Ooi, T., Maruoka, K., & Luxen, A. (2003). Synthesis of [18F]fluorinated a-methyl-a-amino acids by phase transfer catalysis for potential PET application. Journal of Labelled Compounds and Radiopharmaceuticals, 46, 206.
Peer Reviewed verified by ORBi

Plenevaux, A., Lacan, G., Defraiteur, C., Gillet, S., Way, B. M., Rubin, D. J., Lemaire, C., Aerts, J., Melega, W. P., & Luxen, A. (2002). Influence of P-glycoprotein on the tissue distribution in rats of the 5-HT1A antagonist p-[18F]MPPF [Paper presentation]. Society for Neuroscience, 32nd annual meeting, Orlando, United States.

Rubin, D. J., Way, B., Lacan, G., Plenevaux, A., Luxen, A., Cherry, S., & Melega, W. P. (2002). 18F-MPPF Pharmacokinetics in rat hippocampus imaged with MicroPet. Journal of Nuclear Medicine, 43 (S1), 209.
Peer Reviewed verified by ORBi

Zimmer, L., Pain, F., Mauger, G., Plenevaux, A., Le Bars, D., Mastrippolito, R., Pujol, J. F., Renaud, B., & Laniece, P. (2002). The potential of the beta-Microprobe, an intracerebral radiosensitive probe, to monitor the [(18)F]MPPF binding in the rat dorsal raphe nucleus. European Journal of Nuclear Medicine and Molecular Imaging, 29 (9), 1237-47. doi:10.1007/s00259-002-0866-6
Peer Reviewed verified by ORBi

Lemaire, C., Damhaut, P., Lauricella, B., Mosdzianowski, C., Morelle, J. L., Monclus, M., Van Naemen, J., Mulleneers, E., Aerts, J., Plenevaux, A., Brihaye, C., & Luxen, A. (2002). Fast F-18 FDG synthesis by alkaline hydrolysis on a low polarity solid phase supports. Journal of Labelled Compounds and Radiopharmaceuticals, 45 (5), 435-447. doi:10.1002/jlcr.572
Peer Reviewed verified by ORBi

Costes, N., Le Bars, D., Merlet, I., Zimmer, L., Berthier, V., Lionnet, M., Vighi, C., Lavenne, F., Delforge, J., Plenevaux, A., Lemaire, C., Cinotti, L., Luxen, A., & Pujol, J.-F. (2001). Modeling p-18FMPPF pet kinetics for the detremination of local 5-HT1A receptor concentration. Journal of Nuclear Medicine, 42 (S1), 209.
Peer Reviewed verified by ORBi

Lemaire, C., Gillet, S., Ooi, T., Kameda, M., Takeuchi, M., Maruoka, K., Plenevaux, A., & Luxen, A. (2001). Enantioselective synthesis of 2-[18F]fluoro-L-Tyrosine by catalytic phase-transfer alkylation. Journal of Labelled Compounds and Radiopharmaceuticals, 44, 857.
Peer Reviewed verified by ORBi

Plenevaux, A., Lemaire, C., Aerts, J., Lacan, G., Rubins, D., Melega, W. P., Brihaye, C., Degueldre, C., Fuchs, S., Salmon, E., Maquet, P., Laureys, S., Damhaut, P., Weissmann, D., Le Bars, D., Pujol, J.-F., & Luxen, A. (July 2000). [(18)F]p-MPPF: A radiolabeled antagonist for the study of 5-HT(1A) receptors with PET. Nuclear Medicine and Biology, 27 (5), 467-71. doi:10.1016/S0969-8051(00)00113-X
Peer Reviewed verified by ORBi

Lambin, D., Tadino, V., Olynyk, C., Lemaire, C., Plenevaux, A., & Luxen, A. (12 May 2000). Synthèse du 6-fluoro-a-méthyl-L-tryptophane et de ses principaux métabolites [Poster presentation]. 2èmes Rencontres Franco-Belges de chimie organique, Pont-à-Mousson, France.

Plenevaux, A., Weissmann, D., Aerts, J., Lemaire, C., Brihaye, C., Degueldre, C., Le Bars, D., Comar, D., Pujol, J. F., & Luxen, A. (2000). Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats. Journal of Neurochemistry, 75 (2), 803-11. doi:10.1046/j.1471-4159.2000.0750803.x
Peer Reviewed verified by ORBi

Lambin, D., Tadino, V., Olynyk, C., Lemaire, C., Plenevaux, A., & Luxen, A. (03 May 1999). Synthèse du 6-fluoro-a-méthyl-L-tryptophane et d'un de ses métabolites [Poster presentation]. 1 ères Rencontres Franco-Belges de chimie organique, Houffalize, Belgium.

Lambin, D., Tadino, V., Olynyk, C., Lemaire, C., Plenevaux, A., Pujol, J.-F., & Luxen, A. (1999). Synthesis and in vivo evaluation of 6-fluoro-a-methyl-L-tryptophan. American Chemical Society / Abstracts, 256.
Peer reviewed

Plenevaux, A., Lemaire, C., Salmon, E., Laureys, S., Fuchs, S., Maquet, P., Degueldre, C., Aerts, J., Brihaye, C., Damhaut, P., Biver, F., Goldman, S., Le Bars, D., Ginovart, N., Cinotti, L., Pujol, J.-F., & Luxen, A. (1999). 5-HT1A Receptors visualization with p-[18F]MPPF in healthy volunteers [Paper presentation]. XIIIth International Symposium on Radiopharmaceutical Chemistry, Saint Louis, United States.

Plenevaux, A., Weissmann, D., Lemaire, C., Aerts, J., Comar, D., Le Bars, D., Pujol, J.-F., & Luxen, A. (1999). p-[18F]MPPF, 5-HT1A antagonist: comparison to [3H]8-OH-DPAT with autoradiography [Paper presentation]. Society for Neuroscience, 29th annual meeting, Miami, United States.

Gharib, A., Balende, C., Sarda, N., Weissmann, D., Plenevaux, A., Luxen, A., Bobillier, P., & Pujol, J.-F. (1999). Biochemical and autoradiographic measurements of brain serotonin synthesis rate in the freely moving rat: a reexamination of the alpha-methyl-L-tryptophan method. Journal of Neurochemistry, 72 (6), 2593-600. doi:10.1046/j.1471-4159.1999.0722593.x
Peer Reviewed verified by ORBi

Lemaire, C., Guillouet, S., Plenevaux, A., Brihaye, C., Aerts, J., & Luxen, A. (1999). The synthesis of 6-[18F]fluoro-L-dopa by chiral catalytic phase-transfer alkylation. Journal of Labelled Compounds and Radiopharmaceuticals, 42, 113.
Peer Reviewed verified by ORBi

Le Bars, D., Ginovart, N., Hassoun, W., Weissmann, D., Lemaire, C., Plenevaux, A., Aerts, J., Luxen, A., Pujol, J.-F., & Leviel, V. (1999). p-[18F]MPPF, a fluoro analog of WAY-100635 for visualisation of 5-HT1A receptors in cat. Journal of Labelled Compounds and Radiopharmaceuticals, 42, 395.
Peer Reviewed verified by ORBi

Lemaire, C., Plenevaux, A., Aerts, J., Del Fiore, G., Brihaye, C., Le Bars, D., Comar, D., & Luxen, A. (1999). Solid phase extraction : An alternative to the use of rotary evaporators for solvent removal in the rapid formulation of PET radiopharmaceuticals. Journal of Labelled Compounds and Radiopharmaceuticals, 42 (1), 63-75. doi:10.1002/(SICI)1099-1344(199901)42:1<63::AID-JLCR167>3.0.CO;2-R
Peer Reviewed verified by ORBi

Fuchs, S., Plenevaux, A., Degueldre, C., Lemaire, C., Aerts, J., Laureys, S., Salmon, E., Maquet, P., Le Bars, D., Pujol, J.-F., & Luxen, A. (1999). 5-HT1A receptor distribution in the human brain: preliminary PET data with p-[18F]MPPF. Society for Neuroscience / Abstracts, 25, 1462.
Peer reviewed

Damhaut, P., Plenevaux, A., Lemaire, C., Aerts, J., Biver, F., Monclus, M., Luxen, A., & Goldman, S. (1999). In vivo studies of p-[18F]MPPF metabolites in human. Journal of Labelled Compounds and Radiopharmaceuticals, 42, 661.
Peer Reviewed verified by ORBi

Aerts, J., Plenevaux, A., Lemaire, C., Brihaye, C., & Luxen, A. (1998). Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in free mooving rats. Society for Neuroscience / Abstracts, 24, 428.
Peer reviewed

Le Bars, D., Lemaire, C., Ginovart, N., Plenevaux, A., Aerts, J., Brihaye, C., Hassoun, W., Leviel, V., Mekhsian, P., Weissmann, D., Pujol, J. F., Luxen, A., & Comar, D. (1998). High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. Nuclear Medicine and Biology, 25 (4), 343-50. doi:10.1016/S0969-8051(97)00229-1
Peer Reviewed verified by ORBi

Plenevaux, A., Aerts, J., Lemaire, C., Brihaye, C., Le Bars, D., Mekhsian, P., Weissmann, D., Pujol, J.-F., Comar, D., & Luxen, A. (29 May 1997). Métabolisme du p-[18]MPPF (antagoniste 5-HT1A) chez le rat [Poster presentation]. Journées franco-belges de pharmacochimie. Onzièmes journées. De la conception à la réalisation en pharmacochimie, Bruxelles, Belgium.

Aerts, J., Plenevaux, A., Lemaire, C., Brihaye, C., & Luxen, A. (29 May 1997). Métabolisme de la 6-fluoro-L-tyrosine chez le rat [Poster presentation]. Journées franco-belges de pharmacochimie. Onzièmes journées. De la conception à la réalisation en pharmacochimie.

Ginovart, N., Le Bars, D., Lemaire, C., Plenevaux, A., Aerts, J., Pujol, J.-F., Weissmann, D., Mekhsian, P., Luxen, A., Comar, D., & Leviel, V. (25 May 1997). Le p-[18F]MPPF: un nouveau ligand pour l'étude par TEP des récepteurs 5-HT1A [Poster presentation]. 3ème Colloque de la Société des Neurosciences, Bordeaux, France.

Gharib, A., Balende, C., Luxen, A., Riviere, C., Plenevaux, A., Weissmann, D., & Pujol, J.-F. (25 May 1997). Mesure de la synthèse de la sérotonine in vivo et "in situ" dans le système du raphé mesencephalique du rat [Poster presentation]. 3ème Colloque de la Société des Neurosciences, Bordeaux, France.

Plenevaux, A., Aerts, J., Lemaire, C., Brihaye, C., Le Bars, D., Mekhsian, P., Weissmann, D., Pujol, J.-F., Comar, D., & Luxen, A. (1997). Evaluation of p-[18F]MPPF, 5-HT1A antagonist, a potential radiopharmaceutical for PET: tissue distribution, autoradiography and metabolism in rats. Society for Neuroscience / Abstracts, 23, 129.
Peer reviewed

Aerts, J., Plenevaux, A., Lemaire, C., Brihaye, C., & Luxen, A. (1997). Metabolism of no carrier added 2-[18F]fluoro-L-tyrosine in free moving rats. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 145.
Peer Reviewed verified by ORBi

Lambin, D., Lemaire, C., Plenevaux, A., Damhaut, P., & Luxen, A. (1997). Synthesis of a fluorinated analogue of L-threo-3-(3,4-dihydroxyphenyl)serine: 6-fluoro-L-threo-DOPS. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 17.
Peer Reviewed verified by ORBi

Le Bars, D., Ginovart, N., Lemaire, C., Plenevaux, A., Aerts, J., Pujol, J.-F., Mekhsian, P., Weissmann, D., Leviel, V., Luxen, A., & Comar, D. (1997). Microwave improved synthesis of p-[18F]MPPF, 5-HT1A antagonist and PET sudies on cat brain. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 238.
Peer Reviewed verified by ORBi

Damhaut, P., Lemaire, C., Plenevaux, A., Brihaye, C., Christiaens, L., & Comar, D. (1997). No-carrier-added asymmetric synthesis of alpha-methyl-alpha-amino acids labelled with fluorine-18. Tetrahedron, 53 (16), 5785-5796. doi:10.1016/S0040-4020(97)00265-2
Peer Reviewed verified by ORBi

Plenevaux, A., Aerts, J., Lemaire, C., Brihaye, C., Le Bars, D., Mekhsian, P., Weissmann, D., Pujol, J.-F., Comar, D., & Luxen, A. (1997). Tissue distribution, autoradiography and metabolism in rats of p-[18F]MPPF: 5-HT1A antagonist. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 148.
Peer Reviewed verified by ORBi

Lemaire, C., Damhaut, P., Lauricella, B., Morelle, J.-L., Monclus, M., Van Naemen, J., Mulleneers, E., Aerts, J., Plenevaux, A., Brihaye, C., & Luxen, A. (1997). Synthesis of [18F]FDG with alkaline hydrolysis on a low polarity solid phase support. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 256.
Peer Reviewed verified by ORBi

Plenevaux, A., Aerts, J., Lemaire, C., Brihaye, C., Le Bars, D., Mekhsian, P., Weissmann, D., Pujol, J.-F., Comar, D., & Luxen, A. (1997). Evaluation of p-[F-18]MPPF, 5-HT1A antagonist, in rats: tissue distribution, autoradiography and metabolism. Journal of Nuclear Medicine, 38, 56.
Peer Reviewed verified by ORBi

Le Bars, D., Lemaire, C., Plenevaux, A., Aerts, J., Leviel, V., Pujol, J.-F., Luxen, A., & Comar, D. (1997). High yield radiosynthesis of p-[F-18]MPPF, 5-HT1A antagonist, and PET studies in cat brain. Journal of Nuclear Medicine, 38, 56.
Peer Reviewed verified by ORBi

Al-Darwich, M. J., Plenevaux, A., Lemaire, C., De Fiore, G., Christiaens, L., Comar, D., & Luxen, A. (1996). Enantioselective syntheses of no-carrier-added (nca) (S)-4-chloro-2 F-18 fluorophenylalanine and (S)-(alpha-methyl)-4-chloro-2 F-18 fluorophenylalanine. Journal of Fluorine Chemistry, 80 (2), 117-124. doi:10.1016/S0022-1139(96)03488-4
Peer Reviewed verified by ORBi

Lemaire, C., Plenevaux, A., Del Fiore, G., Aerts, J., Luxen, A., Le Bars, D., & Comar, D. (1995). Sep Pak as alternative to rotary evaporators for radiopharmaceutical formulations. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 723.
Peer Reviewed verified by ORBi

Schmitz, F., Plenevaux, A., Del-Fiore, G., Lemaire, C., Comar, D., & Luxen, A. (1995). Fast Routine Production of L-[11C-methyl]methionine with Al2O3KF. Applied Radiation and Isotopes, 46 (9), 893-897. doi:10.1016/0969-8043(95)00181-C
Peer Reviewed verified by ORBi

Plenevaux, A., Lemaire, C., Aerts, J., Del Fiore, G., & Luxen, A. (1995). Fast quality control of short-lived radiopharmaceutical compounds with a photodiode array detector. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 695.
Peer Reviewed verified by ORBi

Schmitz, F., Plenevaux, A., Del Fiore, G., Lemaire, C., Aerts, J., & Luxen, A. (1995). S-, N- and O-[11C]methylations of a Nor precursor adsorbed on Al2O3/KF. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 106.
Peer Reviewed verified by ORBi

Del Fiore, G., Schmitz, F., Plenevaux, A., Lemaire, C., Aerts, J., & Luxen, A. (1995). Fast routine production of L-[11C-methyl]methionine with Al2O3/KF in a disposable unit. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 746.
Peer Reviewed verified by ORBi

Schmitz, F., Del Fiore, G., Plenevaux, A., Lemaire, C., Aerts, J., & Luxen, A. (1995). [1-11C]Bromoethane: an alternative to the use of [1-11C]iodoethane. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 111.
Peer Reviewed verified by ORBi

Salmon, E., Lemaire, C., Degueldre, C., Plenevaux, A., Sadzot, B., Comar, D., & Franck, G. (1995). Glucose hypometabolism in Alzheimer's disease is not related to loss of cortical interneurons bearing 5HT2 receptors. Acta Neurologica Belgica, 95, 50.
Peer Reviewed verified by ORBi

Sadzot, B., Lemaire, C., Maquet, P., Salmon, E., Plenevaux, A., Degueldre, C., Hermanne, J. P., Guillaume, M., Cantineau, R., & Comar, D. (1995). Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls. Journal of Cerebral Blood Flow and Metabolism, 15 (5), 787-97. doi:10.1038/jcbfm.1995.99
Peer Reviewed verified by ORBi

Plenevaux, A., Lemaire, C., Delfiore, G., & Comar, D. (1994). ENANTIOSELECTIVE SYNTHESIS OF NCA (S)-L-([ALPHA-C-11]METHYL)-TRYPTOPHAN. Applied Radiation and Isotopes, 45 (6), 651-653. doi:10.1016/0969-8043(94)90242-9
Peer Reviewed verified by ORBi

Cantineau, R., Guillaume, M., Damhaut, P., Lemaire, C., Plenevaux, A., Gauthier, F., Pourrias, B., & Christiaens, L. (1994). Synthesis and biodistribution of [5-131I]iodotropapride: a potential D2 dopamine receptor imaging agent. Nuclear Medicine and Biology, 21 (2), 255-62. doi:10.1016/0969-8051(94)90017-5
Peer Reviewed verified by ORBi

Plenevaux, A., Al-Darwich, M. J., Lemaire, C., Del Fiore, G., & Comar, D. (1994). Enantioselective syntheses of n.c.a. L-(a-methyl)-[b-11C]-4-chlorophenylalanine and L-(a-[11C]methyl-tryptophan. Journal of Labelled Compounds and Radiopharmaceuticals, 35, 108.
Peer Reviewed verified by ORBi

Al-Darwich, M. J., Plenevaux, A., Lemaire, C., Comar, D., & Luxen, A. (1994). Enantioselective synhteses of n.c.a. L-2-[18F]fluoro-4-chlorophenylalanine and of L-(a-methyl)-2-[18F]fluoro-4-chlorophenylalanine. Journal of Nuclear Medicine, 35, 251.
Peer Reviewed verified by ORBi

Schmitz, F., Plenevaux, A., Del Fiore, G., Lemaire, C., Comar, D., & Luxen, A. (1994). Al2O3/KF in radiochemistry: fast preparation of L-[11C-methyl]methionine without HPLC. Journal of Nuclear Medicine, 35, 82.
Peer Reviewed verified by ORBi

Brihaye, C., Lemaire, C., Damhaut, P., Plenevaux, A., & Comar, D. (1994). Robot-assisted synthesis of [18F]altanserin, 4-[18F]fluorotropapride, 6-[18F]fluoro-L-dopa and 2-[18F]fluoro-L-tyrosine. Journal of Labelled Compounds and Radiopharmaceuticals, 35, 160.
Peer Reviewed verified by ORBi

Damhaut, P., Lemaire, C., Plenevaux, A., Christiaens, L., & Comar, D. (1994). N.C.A. asymmetric syntheses of a-methyl and b-hydroxy a-amino acid labelled with fluorine-18 for probing enzymatic function. Journal of Labelled Compounds and Radiopharmaceuticals, 35, 178.
Peer Reviewed verified by ORBi

Plenevaux, A., Al-Darwich, M. J., Lemaire, C., Delfiore, G., & Comar, D. (1994). ENANTIOSELECTIVE SYNTHESES OF NCA (S)-L-[BETA-C-11]-4-CHLOROPHENYLALANINE AND (S)-L-(ALPHA-METHYL)-[BETA-C-11]-4-CHLOROPHENYLALANINE. Applied Radiation and Isotopes, 45 (3), 361-369. doi:10.1016/0969-8043(94)90051-5
Peer Reviewed verified by ORBi

Lemaire, C., Damhaut, P., Plenevaux, A., & Comar, D. (1994). Enantioselective synthesis of 6-[fluorine-18]-fluoro-L-dopa from no-carrier-added fluorine-18-fluoride. Journal of Nuclear Medicine, 35 (12), 1996-2002.
Peer Reviewed verified by ORBi

Schmitz, F., Plenevaux, A., Del Fiore, G., Lemaire, C., & Comar, D. (1994). 11C-alkylation on Al2O3/MF: a useful method for rapid labelling. Journal of Labelled Compounds and Radiopharmaceuticals, 35, 94.
Peer Reviewed verified by ORBi

Salmon, E., Sadzot, B., Maquet, P., Lemaire, C., Plenevaux, A., Damhaut, P., & Franck, G. (1994). Evolution of striatal metabolic and biochemical dysfunction in striato-nigral degeneration (SND). Journal of Neurology, 241 (S1), 36.
Peer Reviewed verified by ORBi

Plenevaux, A., Lemaire, C., Palmer, A. J., Damhaut, P., & Comar, D. (1993). Non-activated 18F-fluorinated aromatic compounds through nucleophilic substitution and decarbonylation reactions using RhCl[P(C6H5)3]3. Journal of Labelled Compounds and Radiopharmaceuticals, 32, 114.
Peer Reviewed verified by ORBi

Plenevaux, A. (1993). Labeling of amino acids with carbon-11 and fluorine-18 for PET. Journal of Nuclear Biology and Medicine, 37, 150.
Peer Reviewed verified by ORBi

Plenevaux, A., Al-Darwich, M. J., Lemaire, C., Del Fiore, G., Christiaens, L., & Comar, D. (1993). Asymmetric synthesis of n.c.a. L-[2-11C]-4-chlorophenylalanine. Journal of Labelled Compounds and Radiopharmaceuticals, 32, 156.
Peer Reviewed verified by ORBi

Lemaire, C., Plenevaux, A., Damhaut, P., Guillaume, M., Christiaens, L., & Comar, D. (1993). NCA asymmetric synthesis of 2-[18F]fluoro-L-tyrosine. Journal of Labelled Compounds and Radiopharmaceuticals, 32, 139.
Peer Reviewed verified by ORBi

Lemaire, C., Plenevaux, A., Cantineau, R., Christiaens, L., Guillaume, M., & Comar, D. (1993). NUCLEOPHILIC ENANTIOSELECTIVE SYNTHESIS OF 6-[F-18]FLUORO-L-DOPA VIA 2 CHIRAL AUXILIARIES. Applied Radiation and Isotopes, 44 (4), 737-744. doi:10.1016/0969-8043(93)90141-V
Peer Reviewed verified by ORBi

Lemaire, C., Damhaut, P., Plenevaux, A., Cantineau, R., Christiaens, L., & Guillaume, M. (1992). SYNTHESIS OF F-18 SUBSTITUTED AROMATIC-ALDEHYDES AND BENZYL BROMIDES, NEW INTERMEDIATES FOR NCA [F-18] FLUORINATION. Applied Radiation and Isotopes, 43 (4), 485-494.
Peer Reviewed verified by ORBi

Plenevaux, A., Lemaire, C., Palmer, A. J., Damhaut, P., & Comar, D. (1992). SYNTHESIS OF NONACTIVATED F-18 FLUORINATED AROMATIC-COMPOUNDS THROUGH NUCLEOPHILIC-SUBSTITUTION AND DECARBOXYLATION REACTIONS. Applied Radiation and Isotopes, 43 (8), 1035-1040.
Peer Reviewed verified by ORBi

Damhaut, P., Cantineau, R., Lemaire, C., Plenevaux, A., Christiaens, L., & Guillaume, M. (1992). 2- and 4-[18F]fluorotropapride, two specific D2 receptor ligands for positron emission tomography: N.C.A. syntheses and animal studies. International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes, 43 (10), 1265-74. doi:10.1016/0883-2889(92)90205-S
Peer Reviewed verified by ORBi

Lemaire, C., Plenevaux, A., & Comar, D. (1992). Feasibility of multumillicurie preparation of L-6-[18F]fluorodopa by nucleophilic asymmetric synthesis. European Journal of Nuclear Medicine, 19, 951.
Peer Reviewed verified by ORBi

Lemaire, C., Guillaume, M., Cantineau, R., Plenevaux, A., & Christiaens, L. (1991). AN APPROACH TO THE ASYMMETRIC-SYNTHESIS OF L-6-[F-18]FLUORODOPA VIA NCA NUCLEOPHILIC FLUORINATION. Applied Radiation and Isotopes, 42 (7), 629-635.
Peer Reviewed verified by ORBi

Lemaire, C., Guillaume, M., Plenevaux, A., Cantineau, R., Damhaut, P., & Christiaens. (1991). 18F-substituted aromatic aldehydes, key intermediates for nca radiosyntheses. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 134.
Peer Reviewed verified by ORBi

Damhaut, P., Cantineau, R., Lemaire, C., Plenevaux, A., Christiaens, L., & Guillaume, M. (1991). 4-[18F]Fluorotropapride, a specific D2 receptor ligand for PET. Journal of Nuclear Medicine, 32, 935.
Peer Reviewed verified by ORBi

Lemaire, C., Cantineau, R., Guillaume, M., Plenevaux, A., & Christiaens, L. (1991). Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. Journal of Nuclear Medicine, 32 (12), 2266-72.
Peer Reviewed verified by ORBi

Damhaut, P., Cantineau, R., Lemaire, C., Plenevaux, A., Christiaens, L., & Guillaume, M. (1991). 2 and 4-[18F]fluorotropapride, two specific D2 receptor ligand for PET. European Journal of Nuclear Medicine, 18, 526.
Peer Reviewed verified by ORBi

Cantineau, R., Damhaut, P., Plenevaux, A., Lemaire, C., & Guillaume, M. (1991). Synthesis and preliminary animal studies of [131I]iodotropapride: a cerebral dopamine D2 receptor ligand. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 368.
Peer Reviewed verified by ORBi

Plenevaux, A., Cantineau, R., Labar, D., Lemaire, C., & Guillaume, M. (1991). Routine production and improvement in the purification of 3-N-(2'-[18F]fluoroethyl)spiperone for clinical use. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 382.
Peer Reviewed verified by ORBi

Lemaire, C., Guillaume, M., Cantineau, R., Plenevaux, A., & Christiaens, L. (1991). NCA asymmetric synthesis of 6-[18F]fluoro-L-dopa. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 269.
Peer Reviewed verified by ORBi

Plenevaux, A., Fowler, J. S., Dewey, S. L., Wolf, A. P., & Guillaume, M. (1991). The synthesis of no-carrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction. International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes, 42 (2), 121-7. doi:10.1016/0883-2889(91)90060-E
Peer Reviewed verified by ORBi

Lemaire, C., Damhaut, P., Plenevaux, A., Cantineau, R., Christiaens, L., & Guillaume, M. (1991). Asymmetric synthesis of 4-[18F]fluoro-L-m-tyrosine via aromatic fluorination. Journal of Nuclear Medicine, 32, 935.
Peer Reviewed verified by ORBi

Plenevaux, A., Guillaume, M., Brihaye, C., Lemaire, C., & Cantineau, R. (1991). Chemical processing for the production of carrier free selenium-73 from germanium and arsenic targets and synthesis of L-[73Se]selenomethionine. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 100.
Peer Reviewed verified by ORBi

Sadzot, B., Lemaire, C., Cantineau, R., Hermanne, J. P., Plenevaux, A., Maquet, P., Salmon, E., Degueldre, C., Guillaume, M., & Franck, G. (1991). Serotonine-S2 receptor imaging with [18F]altanserin and PET. Results in young normal controls. Journal of Nuclear Medicine, 32, 980.
Peer Reviewed verified by ORBi

Lemaire, C., Damhaut, P., Cantineau, R., Plenevaux, A., & Guillaume, M. (1991). NCA synthesis of an N-w-[18F]fluoroethyl analog of altanserine, a serotonine S2 receptor ligand. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 374.
Peer Reviewed verified by ORBi

Plenevaux, A. (1990). Optimalisation de la production du 73Se par cyclotron. Synthèses de nouveaux composés radiopharmaceutiques marqués par émetteurs gamma et positoniques (75Se, 73Se, 11C et 18F) [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/66507

Cantineau, R., Damhaut, P., Plenevaux, A., Lemaire, C., & Guillaume, M. (26 August 1990). [131I]iodotropapride: a cerebral dopamine D2 receptor ligand [Poster presentation]. 5th Congress - World Federation of Nuclear Medicine & Biology, Montréal, Canada.

Lemaire, C., Sadzot, B., Cantineau, R., Plenevaux, A., Salmon, E., Franck, G., & Guillaume, M. (22 August 1990). [18F]Altansérine: nouveau radioligand des récepteurs sérotoninergiques pour la tomographie par émission de positons (TEP) [Poster presentation]. XXIXème Colloque de Médecine Nucléaire de Langue Française, Québec, Canada.

Sadzot, B., Lemaire, C., Cantineau, R., Salmon, E., Plenevaux, A., Franck, G., & Guillaume, M. (19 June 1990). Imaging serotonin-S2 receptors in humans with PET and the selective S2 antagonist [18F]altanserin. Preliminary results. Journal of Nuclear Medicine, 31, 1584.
Peer Reviewed verified by ORBi

DING, Y. S., SHIUE, C. Y., FOWLER, J. S., WOLF, A. P., & Plenevaux, A. (1990). NO-CARRIER-ADDED (NCA) ARYL [F-18] FLUORIDES VIA THE NUCLEOPHILIC AROMATIC-SUBSTITUTION OF ELECTRON-RICH AROMATIC RINGS. Journal of Fluorine Chemistry, 48 (2), 189-205. doi:10.1016/S0022-1139(00)80432-7
Peer Reviewed verified by ORBi

Plenevaux, A., Guillaume, M., Brihaye, C., Lemaire, C., & Cantineau, R. (1990). Chemical processing for production of no-carrier-added selenium-73 from germanium and arsenic targets and synthesis of L-2-amino-4-([73Se]methylseleno) butyric acid (L-[73Se]selenomethionine). International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes, 41 (9), 829-38. doi:10.1016/0883-2889(90)90060-T
Peer Reviewed verified by ORBi

Plenevaux, A., Dewey, S. L., Fowler, J. S., Guillaume, M., & Wolf, A. P. (1990). Synthesis of (R)-(-)- and (S)-(+)-4-fluorodeprenyl and (R)-(-)- and (S)-(+)-[N-11C-methyl]-4-fluorodeprenyl and positron emission tomography studies in baboon brain. Journal of Medicinal Chemistry, 33 (7), 2015-9. doi:10.1021/jm00169a034
Peer Reviewed verified by ORBi

Plenevaux, A., Cantineau, R., Brihaye, C., Lemaire, C., Christiaens, L., & Guillaume, M. (1990). Synthesis and tissue distribution of four Se-labeled tertiary amines, potential brain pH imaging agents. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology, 17 (6), 601-7. doi:10.1016/0883-2897(90)90136-O
Peer Reviewed verified by ORBi

Plenevaux, A., Demonceau, G., Cantineau, R., Debatisse, D., Selak, I., Brihaye, C., Maquet, P., Sadzot, B., Franck, G., Le Poncin Lafitte, M., Rapin, J., Depresseux, J. C., & Guillaume, M. (1989). Development of a new in vivo tracer of the cerebral pH. Journal of Cerebral Blood Flow and Metabolism, 9S1, 410.
Peer Reviewed verified by ORBi

Plenevaux, A., Dewey, S. L., Fowler, J. S., Guillaume, M., & Wolf, A. P. (1989). Synthesis of carbon-11 and fluorine-18 labeled 4-fluorodeprenyl as probes for functional monoamine oxidase. Journal of Nuclear Medicine, 30, 821.
Peer Reviewed verified by ORBi

Ding, Y.-S., Shiue, C.-Y., Fowler, J. S., Plenevaux, A., & Wolf, A. P. (1989). No-carrier-added aryl [18F]fluorides via the nucleophilic aromatic substitution of electron rich aromatic rings. Journal of Nuclear Medicine, 30, 753.
Peer Reviewed verified by ORBi

Demonceau, G., Cantineau, R., Plenevaux, A., Debatisse, D., Selak, I., Brihaye, C., Maquet, P., & Sadzot, B. (10 October 1988). Evaluation of [73Se]PROMOSE as a tracer of the human cerebral pH [Poster presentation]. International Symposium on Nuclear Medicine, Beijin, China.

Plenevaux, A., Cantineau, R., Guillaume, M., Christiaens, L., & Tihange, G. (1987). Fast chemical synthesis of [75Se]L-selenomethionine. International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes, 38 (1), 59-61. doi:10.1016/0883-2889(87)90237-1
Peer Reviewed verified by ORBi

Demonceau, G., Plenevaux, A., Cantineau, R., Brihaye, C., Schurgers, P., Corhay, J.-L., Merchie, G., & Guillaume, M. (1987). Selenium-73: Un nouvel avenir clinique pour la L-méthionine. Journal de Biophysique et de Biomécanique, 11, 157-159.
Peer reviewed

Cantineau, R., Tihange, G., Plenevaux, A., Christiaens, L., Guillaume, M., Welter, A., & Dereu, N. (1986). Synthesis of 75Se-2-phenyl-1,2-benzisoselenazol-3-(2H)-one (PZ 51; EBSELEN*). A novel biologically active organo-selenium compound. Journal of Labelled Compounds and Radiopharmaceuticals, 23 (1), 59-65. doi:10.1002/jlcr.2580230108
Peer Reviewed verified by ORBi

Christiaens, L., Guillaume, M., Luxen, A., Plenevaux, A., Tihange, G., Pety de Thozée, A., & Lauricella, B. (1982). New trends in selenium-labeled compounds synthesis. Journal of Labelled Compounds and Radiopharmaceuticals, 19, 1511.
Peer Reviewed verified by ORBi

Contact ORBi